Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1050.Time spend outdoors in summer,45229,0.0176280296215912,0.0137782313823555,-0.00937730388782571,0.044633363131008,0.200758702095289
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1060.Time spent outdoors in winter,39479,0.0112966716624917,0.0154403394408275,-0.0189663936415302,0.0415597369665137,0.464396557630991
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X1070.Time spent watching television (TV),47531,0.0548132543546853,0.0138334387100815,0.0276997144829255,0.0819267942264451,7.43165561037194e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X1080.Time spent using computer,39469,-0.0689083119494555,0.0142385913242947,-0.0968159509450731,-0.0410006729538379,1.30627422232465e-06
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X1090.Time spent driving,34227,-0.0487763910098728,0.0155389834107547,-0.0792327984949521,-0.0183199835247936,0.00169687309885574
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1160.Sleep duration,50104,0.0127154707272235,0.0125699008565255,-0.0119215349515664,0.0373524764060134,0.311743402491335
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,16764,-0.0231065072029977,0.0166851089479106,-0.0558093207409024,0.00959630633490713,0.16611432558881
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,16764,0.0263687840519278,0.016287431639048,-0.00555458196060626,0.0582921500644618,0.105473590686561
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,16764,0.00986203827549686,0.0185504446737323,-0.0264968332850184,0.0462209098360122,0.594986891499622
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,16764,-0.0154150688216362,0.0189993737647927,-0.0526538414006298,0.0218237037573574,0.417178441074763
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,16764,-0.0016884801634898,0.0194334280758316,-0.0397779991921197,0.0364010388651401,0.930763684551058
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,16764,0.0174482003763107,0.0409883331658312,-0.0628889326287183,0.0977853333813398,0.670341408957601
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,16764,-0.0625887785790087,0.0433917708756104,-0.147636649495205,0.0224590923371876,0.149205089132456
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,16764,0.039362473797715,0.0290365522854029,-0.0175491686816747,0.0962741162771047,0.175239009509732
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,16764,0.0565642443625973,0.0214959854426433,0.0144321128950164,0.0986963758301782,0.00851151807980184
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,16764,0.0360828761001011,0.0146845343460409,0.00730118878186084,0.0648645634183413,0.0140124314784576
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#18.Location of pain during the past week_Upper back,16764,0.00302985641972402,0.0212727932391389,-0.0386648183289882,0.0447245311684362,0.886743102271216
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#19.Location of pain during the past week_Lower back,16764,0.00313867197601983,0.0119253272013537,-0.0202349693386334,0.0265123132906731,0.79240445991653
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,16764,-0.000857470060152242,0.0153744819196096,-0.0309914546225871,0.0292765145022827,0.955523875363529
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,16764,-0.000961352258300976,0.0228841133652548,-0.0458142144542003,0.0438915099375984,0.966491552536039
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,16764,-0.017966413126702,0.0215771562051599,-0.0602576392888155,0.0243248130354114,0.405048950363474
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,16764,0.0361678670973054,0.0288720045142134,-0.0204212617505529,0.0927569959451636,0.210333566645917
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,16764,0.0175992968633025,0.0271311462018012,-0.0355777496922278,0.0707763434188328,0.516557345363055
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#7.Location of pain during the past week_Left hip,16764,0.0222223066018085,0.0167632912803056,-0.0106337443075906,0.0550783575112076,0.184972756495185
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#8.Location of pain during the past week_Right hip,16764,0.0187403567100236,0.0158920628690926,-0.012408086513398,0.0498887999334452,0.238324369317717
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,16764,0.0108448530942736,0.0197923179746523,-0.0279480901360449,0.049637796324592,0.583745594252428
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120040.Fatigue severity over the past week,16775,0.0726295178810582,0.0226700595500681,0.0281962011629246,0.117062834599192,0.00135897421308591
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120041.Waking unrefreshed severity over the past week,16775,0.0429882577915634,0.0223667139147617,-0.0008505014813696,0.0868270170644964,0.0546258791683837
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120042.Cognitive symptoms severity over the past week,16775,0.044902238810074,0.0242588352022545,-0.00264507818634481,0.0924495558064929,0.0641922668383119
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120098.Mobility problems today,16784,0.0424479391561115,0.0264964927366438,-0.00948518660771031,0.0943810649199334,0.109169792013721
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120099.Self-care problems today,16784,0.0989219740482818,0.0411808852462268,0.0182074389656773,0.179636509130886,0.0163105759215744
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120100.Problems doing usual activities,16784,0.0669934675693084,0.0252634981808818,0.01747701113478,0.116509924003837,0.00801418684496233
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120101.Pain or discomfort today,16784,0.0145266477171414,0.0224713556730372,-0.0295172094020115,0.0585705048362944,0.517995668551209
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120102.Anxiety or depression today,16784,0.00484019287432297,0.0274173979939233,-0.0488979071937667,0.0585782929424127,0.859873995296532
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120103.Scale to indicate how health is today,16729,-0.0102203814291682,0.00518073571945094,-0.0203746234392921,-6.61394190443892e-05,0.0485386338703051
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,16744,0.0315674323119292,0.0276761279465248,-0.0226777784632594,0.0858126430871178,0.254052133333002
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",16718,-0.00784717823315473,0.0283855271212196,-0.0634828113907452,0.0477884549244357,0.78220589860895
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",16754,0.0362372442471775,0.0224916233500733,-0.0078463375189661,0.0803208260133211,0.107167193126788
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,16754,0.0741355418333208,0.0229578840069021,0.0291380891797927,0.119132994486849,0.00124377529572716
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,16761,0.0409375235231556,0.0299010778067076,-0.0176685889779913,0.0995436360243025,0.170986821572518
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120109.Feeling bad about self over the last two weeks,16719,0.00844937446114894,0.0298472844560238,-0.0500513030726578,0.0669500519949557,0.777113751236123
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120110.Trouble concentrating over the last two weeks,16760,0.0202038193966528,0.0298714653544416,-0.0383442526980528,0.0787518914913583,0.49882240356273
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,16742,0.0037825509275734,0.0437417611889665,-0.081951301002801,0.0895164028579478,0.931090188598701
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,16669,0.000536171739530508,0.0600225325901749,-0.117107992137212,0.118180335616273,0.992872825878475
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",11676,0.0647056192913507,0.0309267428113937,0.00408920338101898,0.125322035201682,0.036440209359809
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1269.Exposure to tobacco smoke at home,45313,0.0535342876855259,0.0307407078823832,-0.00671749976394527,0.113786075134997,0.0816064938897689
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,42296,0.00998412151599679,0.0186193908748011,-0.0265098845986134,0.0464781276306069,0.591808155575054
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1289.Cooked vegetable intake,48654,-0.0446578241472583,0.0131272315545182,-0.070387197994114,-0.0189284503004026,0.00066967455077897
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47337,-0.034724844006735,0.0138901952866162,-0.0619496267685029,-0.00750006124496723,0.012424313814
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1309.Fresh fruit intake,48557,-0.0288202503093993,0.0137296745177398,-0.0557304123641693,-0.00191008825462926,0.0358113725013237
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1319.Dried fruit intake,45863,-0.02294012344382,0.0141079232360921,-0.0505916529865605,0.00471140609892044,0.103946874081248
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X134.Number of self-reported cancers,50535,0.0249749819810053,0.0245151138528391,-0.0230746411705593,0.0730246051325699,0.308322484509075
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X135.Number of self-reported non-cancer illnesses,50536,0.0915704833533165,0.0130948263810386,0.0659046236464808,0.117236343060152,2.72643802250772e-12
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X136.Number of operations, self-reported",50536,0.0140704387105251,0.01286514451766,-0.0111452445440886,0.0392861219651387,0.274097581070385
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X137.Number of treatments or medications taken,50536,0.0687823325763592,0.0128171055282836,0.0436608057409234,0.093903859411795,8.06550450198406e-08
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1438.Bread intake,49060,0.0135562562436833,0.00313395221966201,0.0074137098931458,0.0196988025942209,1.52410221598396e-05
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1458.Cereal intake,47956,0.0370067373514396,0.0130356321283536,0.0114568983798665,0.0625565763230128,0.00452896616979789
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1488.Tea intake,48779,0.00612255371520222,0.00300257804038111,0.000237500756055244,0.0120076066743492,0.0414455337868394
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1498.Coffee intake,46553,-0.0916357427438151,0.0131478475055219,-0.117405523854638,-0.0658659616329921,3.21973682586497e-12
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1528.Water intake,46705,-0.0234496439953307,0.0133230243252004,-0.0495627716727234,0.00266348368206203,0.0784000862626031
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1568.Average weekly red wine intake,34404,-0.102793465244522,0.0153559580400028,-0.132891143002928,-0.072695787486117,2.20416910552534e-11
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,34394,-0.0772128618786569,0.0157011691686565,-0.107987153449224,-0.0464385703080902,8.79927000679964e-07
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1588.Average weekly beer plus cider intake,34491,0.0337001636559621,0.0173818108166596,-0.000368185544690633,0.0677685128566149,0.0525316818393865
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1598.Average weekly spirits intake,34350,0.00202609941975661,0.0168842306305478,-0.0310669926161171,0.0351191914556303,0.90448423740961
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1608.Average weekly fortified wine intake,34464,-0.041175821660279,0.0276955419520973,-0.0954590838863897,0.0131074405658318,0.137095015274389
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1737.Childhood sunburn occasions,37893,-0.0294021721921031,0.0155633399792611,-0.0599063185514548,0.00110197416724862,0.0588734378348299
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1807.Father's age at death,37227,-0.000460087125636254,0.00347728108217722,-0.0072755580467036,0.00635538379543109,0.894737978823863
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1845.Mother's age,19211,-0.011493740225272,0.00786483518715424,-0.0269088171920943,0.00392133674155035,0.143919624334972
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1873.Number of full brothers,49632,0.0268413718134164,0.0126663989427201,0.00201522988568504,0.0516675137411477,0.0340869314049065
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1883.Number of full sisters,49639,0.0170577762596756,0.0126570690727614,-0.00775007912293672,0.0418656316422878,0.177765003534653
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20015.Sitting height,50150,0.0177903581263342,0.00395529199421515,0.0100379858176725,0.0255427304349959,6.87940012094183e-06
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20016.Fluid intelligence score,16195,-0.0335722624242333,0.0206055351117926,-0.0739591112433469,0.00681458639488026,0.1032724560592
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20018.Prospective memory result,16874,0.0486342297225167,0.0276593713098553,-0.00557813804479967,0.102846597489833,0.0787099650588879
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),15986,0.00585888437822816,0.00551283765750989,-0.00494627743049122,0.0166640461869475,0.287901849959494
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),15964,0.0115616747322913,0.00552152162522849,0.000739492346843446,0.0223838571177391,0.0362820433642875
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20023.Mean time to correctly identify matches,49932,0.0105658615031231,0.00317375179831562,0.0043453079784245,0.0167864150278217,0.000871778856572063
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#1.Illnesses of father_Heart disease,43961,-0.0150430619785431,0.00676414700297302,-0.0283007901043702,-0.00178533385271594,0.0261574945817302
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,43097,-1.44782546657127e-05,0.0148736284542482,-0.0291667900249922,0.0291378335156608,0.99922332959686
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,43029,0.00602475471020961,0.0200059193786568,-0.0331868472719578,0.045236356692377,0.76330263455448
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#12.Illnesses of father_Severe depression,43069,-0.0375045202063151,0.0168212730668442,-0.0704742154173298,-0.00453482499530042,0.0257798980754024
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,43094,-0.0147067284441122,0.0120365855129645,-0.0382984360495227,0.00888497916129827,0.221776496107475
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#2.Illnesses of father_Stroke,43424,-0.00335196208678701,0.00870193320854719,-0.0204077511755395,0.0137038270019655,0.700093053398966
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#3.Illnesses of father_Lung cancer,43307,0.00558537856154365,0.0109802173368512,-0.0159358474186848,0.0271066045417721,0.610981586861936
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,43110,0.0135813141387563,0.0137494954694651,-0.0133676969813953,0.0405303252589079,0.323271739438675
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,43380,0.027521705523732,0.0100675068564819,0.00778939208502753,0.0472540189624364,0.00626494126048086
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#8.Illnesses of father_High blood pressure,43519,0.00402445419412853,0.00756920722374712,-0.0108111919644158,0.0188601003526729,0.594945044039186
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#9.Illnesses of father_Diabetes,43259,0.0167196444406595,0.0104986448897991,-0.00385769954334667,0.0372969884246657,0.111267898118499
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46086,-0.00225673518660936,0.00772733427659549,-0.0174023103687365,0.0128888399955178,0.770252954286883
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,45802,-0.0122624983728947,0.011078664594863,-0.0339766809788262,0.00945168423303675,0.268361538648452
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,45660,0.0187758547882941,0.024006469278743,-0.0282768249980422,0.0658285345746303,0.43415019068306
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#12.Illnesses of mother_Severe depression,45733,0.00141650198406226,0.0123888129604283,-0.0228655714183772,0.0256985753865018,0.908971009460132
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#2.Illnesses of mother_Stroke,45969,0.00732026177704455,0.00877969158832786,-0.00988793373607806,0.0245284572901672,0.404413761159988
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,45760,0.00956474977076283,0.015565959844373,-0.0209445315242083,0.040074031065734,0.538910630420033
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,45719,0.00499212382078512,0.0139695755820192,-0.0223882443199726,0.0323724919615428,0.720826309782023
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,45758,-0.00789391517152861,0.0113610477782553,-0.0301615688169091,0.0143737384738518,0.487169878967487
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,45803,0.0171152033319954,0.0130799450958167,-0.00852148905580538,0.0427518957197962,0.190707875933542
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46163,0.00850571469488913,0.00667151229060663,-0.00457044939469986,0.0215818787844781,0.202340250833404
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#9.Illnesses of mother_Diabetes,45870,0.0229414097375859,0.0103165274436348,0.00272101594806177,0.0431618035271101,0.0261699134974605
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,39514,-0.00372062654132511,0.0108441041623647,-0.0249750706995598,0.0175338176169096,0.731524057833786
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,39228,0.0500967013728419,0.0436103717085801,-0.035379627175975,0.135573029921659,0.250672833641836
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,39217,0.0609968887452294,0.044059346333725,-0.0253594300688715,0.14735320755933,0.166236042341603
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,39336,-0.00133792549168244,0.0127694488817394,-0.0263660452998916,0.0236901943165268,0.916554479347708
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,39248,0.00116809775891357,0.0255130956313573,-0.0488375696785467,0.0511737651963739,0.963482451269527
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#2.Illnesses of siblings_Stroke,39299,0.0251109597919623,0.0182713891678846,-0.0107009629770916,0.0609228825610162,0.169346391676613
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,39248,-0.0106114797573544,0.0216160298458251,-0.0529788982551716,0.0317559387404627,0.623494336991359
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,39251,0.0172898318643551,0.0211291087082017,-0.0241232212037202,0.0587028849324305,0.41319405800305
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,39276,0.00261503691815191,0.0159731739079279,-0.0286923839413868,0.0339224577776906,0.869956905644065
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,39293,0.0232131603216187,0.0196390804645439,-0.0152794373888873,0.0617057580321248,0.237217559623459
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,39647,0.00952252619510717,0.00810586839477418,-0.00636497585865022,0.0254100282488646,0.240094041372604
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,39431,0.0423728886585001,0.0114921683764715,0.0198482386406161,0.0648975386763842,0.000227119582939434
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20127.Neuroticism score,40154,0.0169350748248456,0.0132044501538529,-0.00894564747670598,0.0428157971263972,0.199664956320446
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,16195,0.0226501717940845,0.0209843761028434,-0.0184792053674886,0.0637795489556575,0.280433275304914
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X20161.Pack years of smoking,15407,0.0203657345905383,0.0058104191181324,0.00897731311899877,0.0317541560620778,0.000457841722118639
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,15407,0.0193881371182415,0.00573134472431763,0.00815470145857899,0.0306215727779041,0.000719230172034333
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20191.Fluid intelligence score,12472,-0.00636850567776375,0.0246590016737698,-0.0547001489583526,0.0419631376028251,0.796208274753508
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,12473,-0.0221456692559711,0.0251527253018503,-0.0714450108475977,0.0271536723356555,0.378633607048653
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20240.Maximum digits remembered correctly,11201,-0.00859747742627155,0.0261696220875081,-0.0598899367177874,0.0426949818652443,0.742517942455574
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20255.Spirometry QC measure,37587,0.0182895761713776,0.0168409816359241,-0.0147187478350336,0.0512979001777888,0.277478863251775
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X20261.avMSE,11042,0.00218265073967531,0.0065272627600628,-0.0106107842700478,0.0149760857493984,0.738091718992875
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X20262.Myopia diagnosis,11042,-0.0089948518054239,0.0312812052081841,-0.0703060140134647,0.0523163104026169,0.773698064522863
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X20280.Glucose-lactate,28860,0.0248161479726168,0.00399880075385196,0.016978498495067,0.0326537974501667,5.51249653582615e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X20281.Spectrometer-corrected alanine,28921,0.0200982711681612,0.00400943996913847,0.0122397688286498,0.0279567735076726,5.39777465564689e-07
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,15818,-0.0485210078095214,0.020957942184982,-0.0895985744920861,-0.00744344112695657,0.0206168729274839
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,15815,-0.0274600207771375,0.0412449555567559,-0.108300133668379,0.0533800921141041,0.505562157917458
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),15812,-0.108296488559693,0.0507985863078013,-0.207861717722983,-0.00873125939640212,0.0330320984700874
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),15812,-0.047975903547055,0.0199435202483345,-0.0870652032337906,-0.0088866038603195,0.0161578580983181
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),15812,-0.0474840157405653,0.0347588803812512,-0.115611421287818,0.0206433898066871,0.171927843090294
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,15822,-0.0901446566740832,0.0444671094004153,-0.177300191098897,-0.0029891222492693,0.0426565655945902
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,15822,-0.0536880629076515,0.0290113439007879,-0.110550296953196,0.00317417113789282,0.0642474019898143
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,15822,-0.0322669031507149,0.0324135381528085,-0.0957974379302197,0.0312636316287898,0.319519990824805
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,15822,0.0180746553901803,0.0503333409938343,-0.080578692957735,0.116728003738096,0.719525781582719
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,15822,-0.0665489035045874,0.0582718399531738,-0.180761709812808,0.0476639028036333,0.253453754014772
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,15822,-0.00768001076922824,0.0337201394933788,-0.0737714841762507,0.0584114626377942,0.819837803955011
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,15822,-0.0241588783758847,0.057621597233147,-0.137097208952853,0.0887794522010833,0.67502614803385
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,15822,-0.0850652998639914,0.0431444105780753,-0.169628344597019,-0.000502255130963913,0.0486679835111906
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),15824,-0.0664332739452271,0.0575786310897966,-0.179287390881228,0.0464208429907743,0.248606385704012
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),15824,-0.0432575697782659,0.0268590587365581,-0.0959013249019197,0.00938618534538788,0.107300135269256
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),15824,-0.0751012966123609,0.0402995911687666,-0.154088495303143,0.0038859020784216,0.0623999849352897
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,15826,0.00353543895506903,0.0680054491590416,-0.129755241396652,0.13682611930679,0.958539243814094
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20600.Liking for adding salt to foods,18286,-0.0131007655274443,0.0198623374364538,-0.0520309469028937,0.025829415848005,0.509532840371141
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20601.Liking for aniseed,18286,0.00479725035471133,0.0196957677047567,-0.0338064543466119,0.0434009550560345,0.807568480078805
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20602.Liking for apple juice,18286,-0.00582864276006799,0.0198455614964628,-0.0447259432931351,0.0330686577729992,0.76899043980555
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20603.Liking for apples,18286,-0.0195012450609809,0.0201993516710213,-0.0590919743361827,0.020089484214221,0.334337680078769
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20604.Liking for asparagus,18286,-0.0581769271401823,0.0201374697278937,-0.0976463678068539,-0.0187074864735106,0.00386937094192562
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20605.Liking for aubergine,18286,-0.0716722486882258,0.0197276147947239,-0.110338373685885,-0.0330061236905669,0.000280812036755147
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20606.Liking for avocados,18286,-0.0592030855674162,0.0201398822820165,-0.0986772548401686,-0.0197289162946638,0.00329053699124707
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20607.Liking for bacon,18286,0.0127831196879856,0.0200928973953599,-0.0265989592069199,0.052165198582891,0.524653450234032
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20608.Liking for baked or steamed fish,18286,-0.0664341416425691,0.0202084220418827,-0.106042648844659,-0.0268256344404791,0.00101290659383987
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20609.Liking for bananas,18286,0.0288414262039939,0.0205333634317465,-0.0114039661222293,0.0690868185302171,0.160153439308807
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20610.Liking for barbequed or grilled meat,18286,-0.0340152823046235,0.0199320559914558,-0.0730821120478769,0.00505154743862987,0.0879205592125681
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20611.Liking for beef steak,18286,-0.0392463077903777,0.0200468533650486,-0.078538140385873,4.55248051176027e-05,0.0502770165371805
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20612.Liking for beetroot,18286,0.00949764316804526,0.0202909346305362,-0.0302725887078057,0.0492678750438962,0.6397378130906
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20613.Liking for bell pepper,18286,-0.0681238191533898,0.0199755553004713,-0.107275907542314,-0.028971730764466,0.000650177401328519
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20614.Liking for bicycling,18286,-0.0506722688752606,0.0199192760776009,-0.0897140499873584,-0.0116304877631629,0.0109710076183638
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20615.Liking for biscuits,18286,0.0387686590927868,0.0198266643482053,-9.16030296956374e-05,0.0776289212152693,0.0505534859345586
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20616.Liking for bitter foods,18286,-0.0659115502588668,0.0196932299959336,-0.104510281050897,-0.0273128194668369,0.00081881402219671
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20617.Liking for bitter or ale,18286,-0.0531353264668969,0.0202134657603911,-0.0927537193572634,-0.0135169335765304,0.00857813272304628
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20618.Liking for black olives,18286,-0.0692877918522417,0.019972994196546,-0.108434860477472,-0.0301407232270114,0.000523460018641269
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20619.Liking for black pepper,18286,-0.0182958742786026,0.0200187350785987,-0.0575325950326561,0.0209408464754509,0.360761711366918
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20620.Liking for blue cheese,18286,-0.0872276654082992,0.0199937392481474,-0.126415394334668,-0.0480399364819303,1.29142380292894e-05
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20621.Liking for bolognese sauce,18286,-0.0459204492939912,0.0200819165964633,-0.0852810058230592,-0.00655989276492317,0.0222272585537047
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20622.Liking for broad beans,18286,-0.0624549803128488,0.0198547556336044,-0.101370301354713,-0.0235396592709842,0.00166016442607369
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20623.Liking for broccoli,18286,-0.0291655679241399,0.0205926395132012,-0.0695271413700143,0.0111960055217345,0.156701721900067
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20624.Liking for brown rice,18286,-0.0281123196272853,0.0200468627342013,-0.0674041705863199,0.0111795313317493,0.160833684114772
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20625.Liking for brussel sprouts,18286,-0.047385731262387,0.0201713229976596,-0.0869215243377998,-0.00784993818697408,0.0188262481133743
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20626.Liking for burgers (meat),18286,-0.0330155124319999,0.0197672003368584,-0.0717592250922424,0.00572820022824258,0.0948935901313671
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20627.Liking for burn of spicy foods,18286,-0.0477333737102734,0.0197423976325172,-0.086428473070007,-0.00903827435053971,0.0156239346684169
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20628.Liking for butter on bread,18286,0.000431632135896758,0.0201498117065341,-0.03906199880891,0.0399252630807035,0.982909936316809
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20629.Liking for butternut squash,18286,-0.0249176055935257,0.0200267068823714,-0.0641699510829737,0.0143347398959223,0.213435007237779
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20630.Liking for cabbage,18286,-0.0365249387003025,0.0200537418970921,-0.0758302728186031,0.002780395417998,0.0685695990736146
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20631.Liking for cake,18286,0.0470140592842777,0.0198858755968198,0.00803774311451091,0.0859903754540444,0.0180797713883019
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20632.Liking for cake icing,18286,-0.00201835776358555,0.0196879080307558,-0.040606657503867,0.0365699419766959,0.918346941667378
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20633.Liking for capers,18286,-0.0630391017526557,0.019732450171223,-0.101714704088253,-0.0243634994170586,0.00140217900290598
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20634.Liking for cauliflower,18286,-0.0370709891139509,0.0203339716067764,-0.0769255734632326,0.00278359523533085,0.0683036518783263
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20635.Liking for cereal or granola bar,18286,0.0224840596001158,0.0198142775614617,-0.0163519244203491,0.0613200436205807,0.256499032362564
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20636.Liking for cheesecake,18286,-0.0199427219428264,0.0197989601347281,-0.0587486838068936,0.0188632399212408,0.313822673179952
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20637.Liking for cherries,18286,-0.025336782847063,0.0209195940511185,-0.0663391871872553,0.0156656214931292,0.225853290843072
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20638.Liking for chicken,18286,-0.0152264215149654,0.020875363016181,-0.0561421330266802,0.0256892899967494,0.465768371837826
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20639.Liking for chilli pepper,18286,-0.0517277927072794,0.0197581859044702,-0.0904538370800411,-0.0130017483345177,0.00885084600142338
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20640.Liking for chips or french fries,18286,0.0154640849150411,0.0200044096503482,-0.0237445579996413,0.0546727278297234,0.43951237894207
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20641.Liking for cigarette smoking,18286,0.00825582596139272,0.0322191994685063,-0.0548938049968797,0.0714054569196652,0.797768930218395
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20642.Liking for cod,18286,-0.0511075607560862,0.0204653267609212,-0.0912196012074918,-0.0109955203046806,0.0125238979628253
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20643.Liking for coffee with sugar,18286,0.0271455446005772,0.021629667832304,-0.0152486043507386,0.069539693551893,0.209489591464277
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20644.Liking for coffee without sugar,18286,-0.0740071488453819,0.0203141487506861,-0.113822880396727,-0.0341914172940372,0.000270085189586773
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20645.Liking for coriander,18286,-0.0585209792583633,0.0198680818042456,-0.0974624195946847,-0.0195795389220418,0.00322863834639957
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20646.Liking for corn flakes,18286,0.045255450428266,0.0198484387250594,0.00635251052714953,0.0841583903293825,0.0226161441958873
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20647.Liking for cream,18286,-0.0211333391493476,0.0198707627338315,-0.0600800341076572,0.0178133558089621,0.287551467646389
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20648.Liking for croissant,18286,-0.0287162824887808,0.0198541036232029,-0.0676303255902585,0.0101977606126969,0.148091987716834
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20649.Liking for cucumber,18286,-0.000341805624725745,0.0200956719931995,-0.0397293227313968,0.0390457114819453,0.986429687556847
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20650.Liking for curry,18286,-0.035068821887719,0.0200031681685809,-0.0742750314981376,0.0041373877226995,0.0795907430872969
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20651.Liking for dairy products,18286,0.0234889530181684,0.0201093558696415,-0.0159253844863289,0.0629032905226657,0.242797434514094
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20652.Liking for dark chocolate,18286,-0.0289895448886282,0.0200396743340008,-0.0682673065832698,0.0102882168060134,0.148024022730876
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20653.Liking for diet fizzy drinks,18286,0.00524939253820288,0.0203128222189055,-0.0345637390108518,0.0450625240872576,0.796079881855312
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20654.Liking for dried fruit,18286,-0.0421577447461229,0.0199290266961644,-0.0812186370706052,-0.00309685242164063,0.0344098769540392
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20655.Liking for eggs,18286,-0.0217941384743334,0.0205441505084414,-0.0620606734708785,0.0184723965222118,0.288774838261967
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20656.Liking for exercising alone,18286,-0.0332346988617705,0.0198205182532331,-0.0720829146381074,0.00561351691456644,0.0936021282840031
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20657.Liking for exercising with others,18286,-0.0266085129977132,0.0197465102872428,-0.0653116731607091,0.0120946471652826,0.177834496525865
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20658.Liking for extra virgin olive oil,18286,-0.0301791693124179,0.0200801596772834,-0.0695362822798934,0.00917794365505764,0.132873167218035
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20659.Liking for fatty foods,18286,-0.00697610705692912,0.0198499923188538,-0.0458820920018825,0.0319298778880242,0.72526135910522
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20660.Liking for fresh tomatoes,18286,-0.0232582015842354,0.0213888605824236,-0.0651803683257856,0.0186639651573147,0.276875359684127
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20661.Liking for fried chicken,18286,0.0179437921978184,0.0198865951606693,-0.0210339343170935,0.0569215187127303,0.366906290641662
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20662.Liking for fried or battered fish,18286,-0.0229324851889094,0.0199827661733073,-0.0620987068885918,0.0162337365107729,0.251143332479139
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20663.Liking for fruit,18286,-0.000925191204340423,0.0220472694225456,-0.0441378392725297,0.0422874568638489,0.966527870211819
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20664.Liking for garlic,18286,-0.0603595057385288,0.0201648971117568,-0.0998827040775722,-0.0208363073994853,0.00276351147655787
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20665.Liking for gherkins,18286,-0.0475566699547992,0.0198930011807286,-0.0865469522690271,-0.00856638764057118,0.0168298724064744
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20666.Liking for globe artichoke,18286,-0.0476916660567628,0.01987957531664,-0.0866556336773773,-0.00872769843614837,0.0164485994837191
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20667.Liking for goat's cheese,18286,-0.0660248869959743,0.019681344939993,-0.104600323078361,-0.027449450913588,0.000796145710694486
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20668.Liking for going to a cafe,18286,0.0126876615721196,0.0200594030892434,-0.0266287684827973,0.0520040916270366,0.527065224817321
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20669.Liking for going to the gym,18286,-0.0403370601637045,0.0196356197512583,-0.0788228748761708,-0.00185124545123828,0.0399628029685827
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20670.Liking for going to the pub,18286,-0.0406081746345868,0.019761592434711,-0.0793408958066204,-0.00187545346255314,0.0399024743871199
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20671.Liking for grapefruit,18286,-0.0397634157342751,0.0197608698774739,-0.0784947206941239,-0.00103211077442629,0.0442103488660802
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20672.Liking for green olives,18286,-0.0575904822594985,0.020085979523597,-0.0969590021257486,-0.0182219623932484,0.00414597435924503
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20673.Liking for haddock,18286,-0.0497523543454243,0.0203860043425226,-0.0897089228567686,-0.00979578583407991,0.0146757643855828
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20674.Liking for ham,18286,-0.00164187374255937,0.0199608304045744,-0.0407651013355253,0.0374813538504066,0.934445013104483
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20675.Liking for hard cheese,18286,-0.0390482665205345,0.020296998928062,-0.0788303844195359,0.000733851378467015,0.0543896211876603
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20676.Liking for herring,18286,-0.0426518744849028,0.0196695662290878,-0.0812042242939149,-0.00409952467589081,0.0301396365178029
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20677.Liking for honey,18286,-0.0099208849228523,0.0198706999739857,-0.0488674568718643,0.0290256870261597,0.617593763365926
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20678.Liking for horseradish or wasabi,18286,-0.0511574154149609,0.0197717128921141,-0.0899099726835045,-0.0124048581464172,0.00967785547159203
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20679.Liking for ice cream,18286,0.00899628783682893,0.0199975081334154,-0.0301988281046653,0.0481914037783232,0.652809200443736
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20680.Liking for jam,18286,0.0286448658795406,0.0199010900442049,-0.010361270607101,0.0676510023661822,0.150065221822891
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20681.Liking for kiwi fruit,18286,-0.00619523462606614,0.0198833997968077,-0.0451666982278092,0.0327762289756769,0.755364633431887
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20682.Liking for lager,18286,-0.00232282747905408,0.0199254388084954,-0.041376687543705,0.0367310325855969,0.907197357976708
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20683.Liking for lamb,18286,-0.0307290914694443,0.0202432967246723,-0.0704059530498019,0.00894777011091337,0.129034609090199
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20684.Liking for lemons,18286,-0.0333149759166265,0.0198989799463085,-0.0723169766113911,0.00568702477813814,0.0941073988195266
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20685.Liking for lentils or beans,18286,-0.0177803714433591,0.0200519147566234,-0.057082124366341,0.0215213814796228,0.375243020041219
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20686.Liking for liver,18286,-0.0637784504258155,0.0200766855888817,-0.103128754180024,-0.0244281466716075,0.0014918727354573
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20687.Liking for mackerel,18286,-0.0510176602916863,0.0199360109316537,-0.0900922417177276,-0.011943078865645,0.0105032261834914
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20688.Liking for marzipan,18286,-0.00936311999789822,0.0197654495989259,-0.048103401211793,0.0293771612159966,0.635711342230274
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20689.Liking for mayonnaise,18286,-0.0467860727600644,0.0199060844224774,-0.0858019982281201,-0.00777014729200869,0.0187668328607664
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20690.Liking for melon,18286,0.0146751570825817,0.020556852812086,-0.0256162744291069,0.0549665885942702,0.475309575933593
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20691.Liking for milk chocolate,18286,0.0145856889826542,0.019965935046649,-0.0245475437087778,0.0537189216740862,0.465076435078514
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20692.Liking for mushrooms,18286,-0.0510317506484727,0.0205347383324209,-0.0912798377800176,-0.0107836635169278,0.0129588409733552
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20694.Liking for orange juice,18286,0.0139928851133821,0.0200045971741557,-0.0252161253479632,0.0532018955747273,0.484258846378372
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20695.Liking for oranges,18286,0.0157437586212056,0.020207152876336,-0.023862261016413,0.0553497782588241,0.435920242183043
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20696.Liking for pasta,18286,-0.0406184253309425,0.0201854349260051,-0.0801818777859125,-0.0010549728759725,0.0442067622970853
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20697.Liking for pears,18286,0.00830383973731456,0.02032279162301,-0.0315288318437851,0.0481365113184143,0.682839932646039
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20698.Liking for pizza,18286,0.00760406307220999,0.0199792315911445,-0.0315552308464331,0.0467633569908531,0.703505714027315
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20699.Liking for plain yogurt,18286,-0.0437664524022757,0.0199840174249522,-0.082935126555182,-0.00459777824936948,0.0285315611536264
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20700.Liking for plums,18286,-0.0190208654729916,0.0202001362501514,-0.0586131325232883,0.0205714015773051,0.346399347103405
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20701.Liking for pollock,18286,-0.0468836657206573,0.0197081125271313,-0.0855115662738346,-0.00825576516747994,0.0173745137192396
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20702.Liking for pork chop,18286,-0.000589291415203519,0.019944602065403,-0.0396807114633934,0.0385021286329864,0.976429127092017
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20703.Liking for porridge,18286,-0.00273136669242405,0.0202393269694196,-0.0424004475524865,0.0369377141676384,0.892650178292459
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20704.Liking for potato crisps,18286,0.0270553749705438,0.0200621591324435,-0.0122664569290455,0.0663772068701331,0.177489457295189
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20705.Liking for potatoes,18286,0.025342634284949,0.0201385481278742,-0.0141289200456844,0.0648141886155823,0.208258096840005
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20706.Liking for prawns,18286,-0.0574972507872715,0.0201809720957678,-0.0970519560949763,-0.0179425454795667,0.00438945521369644
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20707.Liking for raw carrots,18286,-0.0311844468827171,0.0200523517473541,-0.0704870563075311,0.00811816254209687,0.119927296205486
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20708.Liking for red meat,18286,-0.031309408371351,0.0199870623291431,-0.0704840505364715,0.00786523379376961,0.117252735117339
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20709.Liking for red wine,18286,-0.0569795576720452,0.019960412217494,-0.0961019656183334,-0.0178571497257569,0.00431357342352135
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,18286,0.00451943561153656,0.0204605054087969,-0.0355831549897053,0.0446220262127785,0.825183804315999
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20711.Liking for roast chicken,18286,-0.0049290409919011,0.0209371918559611,-0.0459659370295849,0.0361078550457827,0.813885134058085
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20712.Liking for salad dressing,18286,-0.00435663932311413,0.0198554021302012,-0.0432732274983086,0.0345599488520803,0.826326639032552
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20713.Liking for salad leaves,18286,-0.00134956019604071,0.0203357919946731,-0.0412077125056,0.0385085921135186,0.947088925746313
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20714.Liking for salami,18286,-0.0174784940935915,0.0197240743128135,-0.0561376797467059,0.0211806915595229,0.375548216602208
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20715.Liking for salmon,18286,-0.0706546324185403,0.0207585201050443,-0.111341331824427,-0.0299679330126535,0.000666359363264495
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20716.Liking for salty foods,18286,-0.000379915631864389,0.0197481553159401,-0.0390863000511069,0.0383264687873781,0.984651428706195
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20717.Liking for salty pretzels,18286,-0.0108524694368098,0.0198448075638446,-0.0497482922619452,0.0280433533883257,0.584476822850394
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20718.Liking for sardines,18286,-0.0596009489152384,0.0197969419799953,-0.0984029551960292,-0.0207989426344475,0.00261076343144734
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20719.Liking for sausages (meat),18286,-0.0230710221416733,0.0198479623485701,-0.0619730283448707,0.0158309840615241,0.245093312040063
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20720.Liking for savoury biscuits,18286,0.00792371595969835,0.0199728205456025,-0.0312230123096826,0.0470704442290793,0.691574944990154
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20721.Liking for shellfish (other than prawns),18286,-0.0728803004195492,0.0197418014679795,-0.111574231296789,-0.0341863695423095,0.000223430962399976
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20722.Liking for skimmed milk,18286,-0.0155677026615005,0.0198206950366468,-0.0544162649333282,0.0232808596103272,0.432213633172508
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20723.Liking for smoked fish,18286,-0.0812943047438788,0.019999694116528,-0.120493705212274,-0.0420949042754839,4.82796019201264e-05
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20724.Liking for soft cheese,18286,-0.0553840122860543,0.0198871829563526,-0.0943628908805054,-0.0164051336916031,0.00535977315521207
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20725.Liking for soy sauce,18286,-0.0110101899655502,0.0200775535791942,-0.0503621949807709,0.0283418150496705,0.583435619076136
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20726.Liking for soya milk,18286,-0.00281196583597543,0.0199067095653057,-0.0418291165839745,0.0362051849120237,0.887668326615808
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20727.Liking for spicy foods,18286,-0.0358628124276175,0.0198306067261856,-0.0747308016109412,0.00300517675570632,0.0705517429658529
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20728.Liking for spinach,18286,-0.0448222983258795,0.0200391801625015,-0.0840990914443825,-0.0055455052073765,0.0253158076535577
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20729.Liking for spirits,18286,-0.0357148460785818,0.0196715331979378,-0.0742710511465399,0.00284135898937633,0.0694543078064062
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20730.Liking for strawberries,18286,0.0179185524943531,0.0217069887546028,-0.0246271454646684,0.0604642504533747,0.409113381370359
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20731.Liking for sweet coffee house drinks,18286,0.00330160084222502,0.0203260469518904,-0.0365374511834802,0.0431406528679303,0.870967455251544
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20732.Liking for sweet foods,18286,0.0236623795765962,0.0198742025509814,-0.0152910574233274,0.0626158165765198,0.233823082796948
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20733.Liking for taking the stairs,18286,-0.0288177478313835,0.0203912624527291,-0.0687846222387326,0.0111491265759656,0.157602210764341
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20734.Liking for tea with sugar,18286,0.0320883572624126,0.0241327256794645,-0.0152117850693379,0.0793884995941631,0.183646418097045
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20735.Liking for tea without sugar,18286,0.00537053841298364,0.0208906056484534,-0.0355750486579851,0.0463161254839524,0.797120595733883
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20736.Liking for tomato ketchup,18286,-0.00520556678543073,0.019858083187495,-0.0441274098329209,0.0337162762620595,0.793217674650235
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20737.Liking for tinned tuna,18286,-0.0238225426814892,0.0200598320723523,-0.0631398135432997,0.0154947281803212,0.235016580649021
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20738.Liking for turnip (white),18286,-0.0235212665108713,0.0198096690500006,-0.0623482178488725,0.0153056848271298,0.235099941901722
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20739.Liking for vegetables,18286,-0.0393765939842385,0.021891647114183,-0.0822842223280372,0.00353103435956024,0.0720820153261661
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20740.Liking for vinegar,18286,0.00831226376016362,0.0199098658630815,-0.0307110733314761,0.0473356008518033,0.676321497487106
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20741.Liking for watching television,18286,0.0621393574336317,0.0200664164212086,0.0228091812480628,0.101469533619201,0.00195994584888823
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20742.Liking for whisky,18286,-0.0177932716247244,0.0206614501606559,-0.05828971393961,0.0227031706901612,0.389149047521916
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20743.Liking for white bread,18286,-0.009299629020338,0.0196838530405814,-0.0478799809798775,0.0292807229392015,0.636611534406949
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20744.Liking for white rice,18286,-0.0306370357327706,0.0200976261146894,-0.0700283829175619,0.00875431145202076,0.127423471180559
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20745.Liking for white wine,18286,-0.0215316258696334,0.0198339838767172,-0.0604062342679991,0.0173429825287324,0.277673609925482
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,18286,-0.0263446791340267,0.0200263023624373,-0.0655962317644038,0.0129068734963504,0.188357117193047
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20747.Liking for whole milk,18286,0.0404832847709799,0.0198001450307263,0.00167500051075638,0.0792915690312034,0.040909073296562
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20748.Liking for wholemeal bread,18286,-0.0134856938718802,0.0207271541109999,-0.0541109159294401,0.0271395281856797,0.51529399355303
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20749.Liking for working up a sweat,18286,-0.0497421711494474,0.0200871093138141,-0.089112905404523,-0.0103714368943719,0.0132833329429636
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X21001.Body mass index (BMI),50302,-0.126184658611527,0.0130493504675463,-0.151761385527917,-0.100607931695136,4.23521211600996e-22
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X21002.Weight,50342,0.00280409182276064,0.00735635272635502,-0.0116143595208952,0.0172225431664165,0.703071570872195
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X21021.Pulse wave Arterial Stiffness index,16751,0.0142691762199168,0.00544828029699711,0.00359054683780244,0.0249478056020311,0.00882612671571705
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,17465,-0.00563887979820027,0.0214889555346535,-0.0477572326461211,0.0364794730497206,0.793009790339463
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,17482,-0.00959751390340374,0.0220886777603557,-0.0528913223137009,0.0336962945068934,0.663931307810148
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,17484,-0.0217748015109423,0.0218967986622524,-0.064692526888957,0.0211429238670723,0.320028055031796
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21040.Satisfaction with bowel habits,17408,0.0521485809559977,0.0203051891292223,0.012350410262722,0.0919467516492735,0.0102299360767046
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,17391,0.0467124194183221,0.0216417532144425,0.00429458311801484,0.0891302557186294,0.0309073187893023
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21042.Greatest number of times bowels opened per day,17400,0.0543603346645012,0.0217564535353817,0.011717685735153,0.0970029835938493,0.0124782025998858
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21043.Least number of times bowels opened per week,17277,0.007782886029747,0.0217133945480893,-0.0347753672845081,0.0503411393440021,0.720020619870715
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21044.Average number of times bowels opened per day,17337,0.070987803933272,0.0245190095725284,0.0229305451711163,0.119045062695428,0.00379372520852774
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,17493,0.0187057960926372,0.022100408545161,-0.0246110046558784,0.0620225968411527,0.397340966708668
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,17484,0.0195379828709088,0.0221723166352323,-0.0239197577341465,0.0629957234759641,0.378228110713591
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,9805,-0.0509422230975468,0.0347437044493254,-0.119039883818225,0.017155437623131,0.142618059339391
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,17488,0.0622126366463266,0.0240352414131706,0.0151035634765123,0.109321709816141,0.00965049085675731
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,17485,0.00453232100317004,0.0333155376988821,-0.0607661328866388,0.0698307748929789,0.891789441249307
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,17486,0.0126566817277369,0.0259798499598447,-0.0382638241935588,0.0635771876490326,0.626141841901778
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,17485,-0.0425011038624316,0.0650096596463064,-0.169920036769192,0.0849178290443288,0.513271192111233
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,17492,0.0131854280776491,0.0253096400992691,-0.0364214665169182,0.0627923226722165,0.602397989784677
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,17488,-0.0712442780437865,0.0253195165093645,-0.120870530402141,-0.0216180256854321,0.00490130294781835
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,17091,0.038366950548394,0.0229129974406448,-0.00654252443526986,0.0832764255320579,0.0940580898584434
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,17483,-0.00626250900857381,0.0226088488359202,-0.0505758527269774,0.0380508347098298,0.781788210408744
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,17489,-0.0287816766188719,0.0330480913989935,-0.0935559357608993,0.0359925825231554,0.383819170902279
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,17492,-0.053729823960791,0.0221975763587167,-0.0972370736238758,-0.0102225742977062,0.0155081700675716
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,17489,-0.0480815066090267,0.0219957528669544,-0.0911931822282573,-0.00496983098979615,0.0288328510148585
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X21100.Water hardness (USGS classification),50030,-0.00825216315773933,0.0127819469320449,-0.0333047791445473,0.0168004528290686,0.518534394302093
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2139.Age first had sexual intercourse,43631,-0.00749559136267433,0.00335158045555249,-0.0140646890555572,-0.000926493669791453,0.0253283345393722
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2149.Lifetime number of sexual partners,40487,-0.0189713241385843,0.0144764503096583,-0.0473451667455145,0.00940251846834594,0.190035675399171
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22032.IPAQ activity group,40451,-0.043534417278132,0.0141436873433785,-0.0712560444711538,-0.0158127900851102,0.00208527026160555
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22033.Summed days activity,41524,-0.0118934815603936,0.00327501088112033,-0.0183125028873894,-0.00547446023339775,0.000282024380308627
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22034.Summed minutes activity,40451,-0.00992824497880122,0.00330062977932947,-0.016397479346287,-0.00345901061131546,0.00263147816289941
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22037.MET minutes per week for walking,38717,-0.00345449876007333,0.00336486842438572,-0.0100496408718693,0.00314064335172268,0.304597793946511
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22038.MET minutes per week for moderate activity,40451,-0.00963466355768105,0.00330519626175209,-0.0161128482307151,-0.00315647888464696,0.00355877962759745
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22039.MET minutes per week for vigorous activity,40451,-0.0733194229982595,0.0141538589799413,-0.101060986598944,-0.0455778593975746,2.22742970037371e-07
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22040.Summed MET minutes per week for all activity,38717,-0.00859853938105716,0.00338160121046197,-0.0152264777535626,-0.00197060100855171,0.0110025009408934
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X2217.Age started wearing glasses or contact lenses,42955,0.00243808791331984,0.0032888288204535,-0.00400801657476901,0.0088841924014087,0.458501034608498
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X22501.Year ended full time education,12286,-0.0328123016785642,0.0146779474901957,-0.0615810787593479,-0.00404352459778058,0.0254035714513945
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X22506.Tobacco smoking,12206,-0.0706512704320766,0.0530781963801611,-0.174684535337192,0.0333819944730392,0.183187925130309
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47221,-0.0144267517882757,0.0334084669551954,-0.0799073470204586,0.0510538434439073,0.665867522500158
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23098.Weight,49491,0.00402633791652328,0.00741487834335589,-0.0105068236364543,0.0185594994695008,0.58712677226693
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23099.Body fat percentage,49462,-0.00330468167790914,0.00710766756428845,-0.0172357101039145,0.0106263467480962,0.641972167514137
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23100.Whole body fat mass,49410,0.00252286021743558,0.00686873035323227,-0.0109398512748997,0.0159855717097708,0.713399481548212
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23101.Whole body fat-free mass,49485,0.00856035771409315,0.00619254071775799,-0.00357702209271251,0.0206977375208988,0.166865592205524
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23102.Whole body water mass,49491,0.00771276868637278,0.00620093513903892,-0.0044410641861435,0.0198666015588891,0.213576368483843
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23104.Body mass index (BMI),49491,-0.120181744710101,0.0131021135627486,-0.145861887293088,-0.0945016021271137,4.78506088857787e-20
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23105.Basal metabolic rate,49489,0.00803797038442268,0.0066282758953717,-0.00495345037050584,0.0210293911393512,0.22525839672767
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23106.Impedance of whole body,49486,0.0106245507306822,0.00507489311739684,0.000677760220584356,0.02057134124078,0.0363050186290668
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23107.Impedance of leg (right),49488,-0.00259097524364032,0.00413691979763652,-0.0106993380470079,0.00551738755972727,0.531117529090628
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23108.Impedance of leg (left),49487,-0.00128135249200014,0.00410785722517887,-0.00933275265335072,0.00677004766935045,0.755097148390733
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23109.Impedance of arm (right),49479,0.0166044293381491,0.00505145717537986,0.00670357327440456,0.0265052854018936,0.00101310741008901
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23110.Impedance of arm (left),49486,0.015673749873397,0.00505727321745245,0.00576149436719024,0.0255860053796039,0.00194120563988682
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23111.Leg fat percentage (right),49487,-0.0326182910573988,0.00859708963882093,-0.0494685867494878,-0.0157679953653098,0.000148351178386017
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23112.Leg fat mass (right),49486,-0.00241004030063872,0.00914058586598332,-0.020325588597966,0.0155055079966886,0.792040200107997
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23113.Leg fat-free mass (right),49485,0.0211530798735028,0.0064839065552066,0.00844462302529788,0.0338615367217078,0.00110548986022203
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23114.Leg predicted mass (right),49484,0.0214179848321828,0.00651607678569277,0.00864647433222495,0.0341894953321406,0.00101351210330409
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23115.Leg fat percentage (left),49481,-0.034010491392248,0.0089583455517815,-0.0515688486737397,-0.0164521341107563,0.000146919664580915
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23116.Leg fat mass (left),49481,-0.00563706153238736,0.0095337254410136,-0.024323163396774,0.0130490403319993,0.554338315540507
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23117.Leg fat-free mass (left),49478,0.0218549559468306,0.00676979265027247,0.0085861623522966,0.0351237495413647,0.0012460724511149
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23118.Leg predicted mass (left),49477,0.0223651861459481,0.00680433026656705,0.00902869882347667,0.0357016734684195,0.00101365603447495
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23119.Arm fat percentage (right),49477,-0.016061480427521,0.00788885935834997,-0.0315236447698869,-0.000599316085155037,0.0417586919123474
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23120.Arm fat mass (right),49472,-0.0266173007088899,0.00781784198708965,-0.0419402710035857,-0.0112943304141942,0.000662926365440868
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23121.Arm fat-free mass (right),49473,0.00407141630578635,0.00623701760126165,-0.00815313819268648,0.0162959708042592,0.513899503630533
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23122.Arm predicted mass (right),49472,0.00271297658357252,0.00624557253540256,-0.00952834558581649,0.0149542987529615,0.664011532386177
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23123.Arm fat percentage (left),49468,-0.0133667417596183,0.00808931034818028,-0.0292217900420516,0.00248830652281507,0.0984602565681012
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23124.Arm fat mass (left),49467,-0.0246923719555428,0.00780173800847163,-0.0399837784521472,-0.00940096545893837,0.00155185728461854
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23125.Arm fat-free mass (left),49463,-6.05208298578326e-05,0.00636120779556675,-0.0125284881091687,0.012407446449453,0.992409041698183
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23126.Arm predicted mass (left),49460,-0.000358481180526796,0.00637921296657837,-0.0128617385950204,0.0121447762339668,0.955186528022724
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23127.Trunk fat percentage,49457,0.00158747415897481,0.00509666738517743,-0.00840199391597296,0.0115769422339226,0.755442396974954
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23128.Trunk fat mass,49453,0.00744527575759079,0.00561232708996743,-0.00355488533874537,0.0184454368539269,0.184649366588916
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23129.Trunk fat-free mass,49446,0.00148590627617064,0.00561532658023261,-0.00952013382108527,0.0124919463734265,0.791306256778693
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23130.Trunk predicted mass,49441,0.00113847780232087,0.0056165330845084,-0.00986992704331558,0.0121468826479573,0.839369446475301
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23400.Total Cholesterol,28931,-0.0579793737828826,0.00403696525960635,-0.065891825691711,-0.0500669218740541,1.29454636487938e-46
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,28931,-0.0469189911695955,0.00391804335988159,-0.0545983561549634,-0.0392396261842276,5.74251460027292e-33
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",28931,-0.0340318505627166,0.00393029404726525,-0.0417352268953565,-0.0263284742300767,5.00854687760948e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23403.VLDL Cholesterol,28931,-0.0163516274173634,0.00394534977700956,-0.0240845129803021,-0.00861874185442467,3.41477518767111e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23404.Clinical LDL Cholesterol,28931,-0.056146436528642,0.00391786798035085,-0.0638254577701297,-0.0484674152871543,2.02488989635803e-46
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23405.LDL Cholesterol,28931,-0.0569361158499255,0.00390662064801698,-0.0645930923200388,-0.0492791393798122,6.0595014762661e-48
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23406.HDL Cholesterol,28931,-0.0564390153156038,0.00454739234931183,-0.065351904320255,-0.0475261263109527,2.79174765944851e-35
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23407.Total Triglycerides,28931,0.0038532116195587,0.00418012410671354,-0.00433983162959982,0.0120462548687172,0.35664394043492
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23408.Triglycerides in VLDL,28931,0.00240057345711187,0.00421283504705078,-0.00585658323510766,0.0106577301493314,0.56880167327405
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23409.Triglycerides in LDL,28931,-0.00273142753599018,0.00404867365210322,-0.0106668278941125,0.00520397282213212,0.499905143901271
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23410.Triglycerides in HDL,28931,0.0154711576421276,0.00402576434369874,0.0075806595284781,0.0233616557557772,0.000121781304805416
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,28931,-0.0487223933211856,0.00410226526065209,-0.0567628332320637,-0.0406819534103075,1.85578883098903e-32
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23412.Phospholipids in VLDL,28931,-0.00794516495553776,0.00403860566073229,-0.015860832050573,-2.9497860502473e-05,0.0491577216211519
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23413.Phospholipids in LDL,28931,-0.0551148929757263,0.00389914224450397,-0.0627572117749541,-0.0474725741764985,3.2639185302039e-45
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23414.Phospholipids in HDL,28931,-0.0379060172186285,0.00439368780653995,-0.0465176453194468,-0.0292943891178102,6.59315162406461e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23415.Total Esterified Cholesterol,28931,-0.0612564651956355,0.00405526913848791,-0.0692047927070718,-0.0533081376841992,2.3437922830895e-51
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,28931,-0.0184195619660919,0.00392181977575654,-0.0261063287265747,-0.0107327952056091,2.65628197647028e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23417.Cholesteryl Esters in LDL,28931,-0.0550676041484553,0.00389988545617357,-0.0627113796425555,-0.0474238286543551,4.02244580284503e-45
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23418.Cholesteryl Esters in HDL,28931,-0.0589175851946393,0.00453154265205075,-0.0677994087926588,-0.0500357615966199,1.5356059874897e-38
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23419.Total Free Cholesterol,28931,-0.0490066311634595,0.00399393861699592,-0.0568347508527715,-0.0411785114741475,1.59478542790246e-34
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23420.Free Cholesterol in VLDL,28931,-0.01339723310947,0.00399992426761079,-0.0212370846739871,-0.00555738154495284,0.000810985381644823
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23421.Free Cholesterol in LDL,28931,-0.0603236980917463,0.00394284510570043,-0.0680516744989191,-0.0525957216845734,1.23846217856929e-52
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23422.Free Cholesterol in HDL,28931,-0.0437771425943928,0.00454969588690424,-0.0526945465327252,-0.0348597386560605,6.96339266136324e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,28931,-0.043261553493273,0.00396329585835622,-0.0510296133756512,-0.0354934936108948,1.10012844890996e-27
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23424.Total Lipids in VLDL,28931,-0.00509363385646168,0.00409138156371907,-0.0131127417213511,0.0029254740084277,0.213154075234039
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23425.Total Lipids in LDL,28931,-0.0544973314896157,0.00390259239914798,-0.0621464125919457,-0.0468482503872857,3.57830647747019e-44
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23426.Total Lipids in HDL,28931,-0.0443323701418267,0.00445294104686265,-0.0530601345936775,-0.0356046056899759,2.59510856600684e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,28931,-0.070747970639979,0.00416333480702222,-0.0789081068617425,-0.0625878344182154,1.89983239056343e-64
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23428.Concentration of VLDL Particles,28931,-0.0126904347940726,0.00398015985454517,-0.0204915481089811,-0.00488932147916405,0.00143203245642423
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23429.Concentration of LDL Particles,28931,-0.0401995390178562,0.00389966126338498,-0.0478428750940908,-0.0325562029416217,7.12502479021304e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23430.Concentration of HDL Particles,28931,-0.0678096728417228,0.00418039421159141,-0.076003245496442,-0.0596161001870037,6.5380121570892e-59
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23431.Average Diameter for VLDL Particles,28931,-0.000228250707881079,0.00437428425933222,-0.00880184785617224,0.00834534644041008,0.958385528199546
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23432.Average Diameter for LDL Particles,28931,-0.0250095189755331,0.00408762664135953,-0.0330212671925978,-0.0169977707584684,9.57635841556533e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23433.Average Diameter for HDL Particles,28931,0.00712060006745252,0.0046689195284055,-0.00203048220822225,0.0162716823431273,0.127243443230432
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23434.Phosphoglycerides,28909,-0.0438895884853169,0.00413150012477359,-0.0519873287298731,-0.0357918482407606,2.60071264181491e-26
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,28909,0.0280100907758155,0.0044351444299726,0.0193172076930692,0.0367029738585618,2.732298980519e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23436.Total Cholines,28909,-0.0490945916762807,0.00416576813534522,-0.0572594972215573,-0.040929686131004,5.50573045607155e-32
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23437.Phosphatidylcholines,28909,-0.046257152695863,0.00418477636179017,-0.0544593143649717,-0.0380549910267543,2.39853139815003e-28
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23438.Sphingomyelins,28908,-0.0565647021387216,0.00419115345818115,-0.0647793629167567,-0.0483500413606866,2.19784943435451e-41
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23439.Apolipoprotein B,28931,-0.0371063595332262,0.00390537316238592,-0.0447608909315026,-0.0294518281349498,2.22600427194912e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23440.Apolipoprotein A1,28931,-0.0511523909919077,0.00433150631154128,-0.0596421433625286,-0.0426626386212868,4.13839038859781e-32
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,28931,-0.00809638019692411,0.00399528193051507,-0.0159271327807336,-0.000265627613114576,0.0427242345887028
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23442.Total Fatty Acids,28909,-0.0241816614197257,0.00398047867059226,-0.0319833996140866,-0.0163799232253649,1.25485664632618e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23443.Degree of Unsaturation,28909,-0.0481870509438902,0.00429754378660538,-0.0566102367656368,-0.0397638651221437,4.05756012853964e-29
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23444.Omega-3 Fatty Acids,28909,-0.0406435694189393,0.00405685404399668,-0.0485950033451728,-0.0326921354927058,1.38137350731683e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23445.Omega-6 Fatty Acids,28909,-0.0395730499246118,0.00397696685072917,-0.047367904952041,-0.0317781948971827,2.7337725410649e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,28909,-0.0441814639689961,0.00399651777813819,-0.0520146388141469,-0.0363482891238452,2.3637549485138e-28
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23447.Monounsaturated Fatty Acids,28909,-0.00460083404417509,0.00408130378090126,-0.0126001894547416,0.00339852136639138,0.259627064298659
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23448.Saturated Fatty Acids,28909,-0.0218067411254482,0.00400313306501849,-0.0296528819328844,-0.0139606003180119,5.15227849559899e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23449.Linoleic Acid,28909,-0.0280689975015864,0.00396520229161617,-0.0358407939931541,-0.0202972010100187,1.48692175669165e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23450.Docosahexaenoic Acid,28909,-0.0531652279342917,0.00416749389396003,-0.0613335159664534,-0.0449969399021301,3.5849029899469e-37
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,28909,-0.0355555420928036,0.00409088694286753,-0.0435736805008239,-0.0275374036847832,3.76568889140076e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,28909,-0.0115330348949134,0.00426488791086739,-0.0198922152002135,-0.00317385458961334,0.0068512772685938
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,28909,-0.0263323910689953,0.00434332819841963,-0.0348453143378978,-0.0178194678000929,1.35494385888496e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,28909,0.0403058594669661,0.00440971949385836,0.0316628092590037,0.0489489096749285,6.628506669009e-20
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,28909,-0.000373963544793616,0.00400206620647618,-0.00821801330948694,0.00747008621989971,0.925552581987954
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,28909,-0.00696501515569195,0.00425748949557395,-0.0153096945670169,0.00137966425563299,0.101862162111617
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,28909,-0.0382628841964757,0.00419143878335961,-0.0464781042118606,-0.0300476641810909,7.36363509050695e-20
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,28909,-0.0357437599042415,0.00441619551020766,-0.0443995031042485,-0.0270880167042345,6.00882767557117e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,28907,0.0286081004736981,0.00405164920230918,0.0206668680371721,0.0365493329102241,1.69221215708147e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23460.Alanine,28921,0.0187980977907862,0.00396804367153992,0.011020732194568,0.0265754633870044,2.17535530185698e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23461.Glutamine,28844,-0.00548871030198589,0.0039526433026377,-0.0132358911751558,0.002258470571184,0.164959771428258
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23462.Glycine,28897,0.0191528288705633,0.00417284934208409,0.0109740441600785,0.0273316135810481,4.45391595308572e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23463.Histidine,28895,-0.0104129542995878,0.00392267446920998,-0.0181013962592394,-0.00272451233993624,0.00794566696148797
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),28911,0.00369871595033175,0.00416535050588345,-0.00446537104119982,0.0118628029418633,0.374563031911406
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23465.Isoleucine,28925,0.00614438612798437,0.00406316661101579,-0.00181942042960657,0.0141081926855753,0.130489816652597
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23466.Leucine,28926,-0.00199980119223463,0.00415570655776537,-0.0101449860454547,0.00614538366098549,0.630365143566411
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23467.Valine,28911,0.00556827791065825,0.00417089747573401,-0.00260668114178041,0.0137432369630969,0.181876679861867
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23468.Phenylalanine,28921,0.0332571563006906,0.00396222989383252,0.0254911857087789,0.0410231268926024,4.92947980725863e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23469.Tyrosine,28898,0.0252706931345329,0.00403018570833928,0.0173715291461879,0.0331698571228779,3.65320505504268e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23470.Glucose,28878,0.0219855787096259,0.00399027871284531,0.0141646324324491,0.0298065249868027,3.6233693191322e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23471.Lactate,28878,0.00766582492572985,0.00396147822646628,-9.86723981440561e-05,0.0154303222496038,0.0529887606035251
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23472.Pyruvate,28844,0.00394709676815751,0.00395127794900652,-0.00379740801189526,0.0116916015482103,0.317831262182347
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23473.Citrate,28927,0.0200373302761165,0.00399449094869516,0.012208128016674,0.027866532535559,5.30039574133801e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23474.3-Hydroxybutyrate,28455,-0.00479825825688161,0.00401955212237013,-0.0126765804167271,0.00308006390296384,0.232593723354934
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23475.Acetate,28905,-0.0128093174102817,0.00393916979874071,-0.0205300902158135,-0.00508854460474991,0.00114815803215517
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23476.Acetoacetate,28929,-0.0137114537563739,0.00394119107884278,-0.0214361882709057,-0.00598671924184202,0.000504005315892877
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23477.Acetone,28929,-0.0204992876037376,0.00394609685523726,-0.0282336374400027,-0.0127649377674726,2.06299428791618e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23478.Creatinine,28199,0.0366430056895512,0.00467628204436962,0.0274774928825868,0.0458085184965157,4.81718813688253e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23479.Albumin,28928,-0.0589935214560499,0.00398630874756185,-0.0668066866012711,-0.0511803563108287,2.25353364391726e-49
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23480.Glycoprotein Acetyls,28931,0.0312559844005413,0.00419236443417795,0.0230389501095526,0.0394730186915301,9.20671213669439e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,28931,0.0207935085274399,0.00422381344482958,0.0125148341755739,0.0290721828793059,8.57301366869958e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,28931,0.0219922494946173,0.00421444394754649,0.0137319393574262,0.0302525596318084,1.81813863995941e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,28931,0.0216802176104629,0.00423953701712829,0.0133707250568914,0.0299897101640343,3.1772528999391e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,28931,0.0204321910306402,0.00419930981695599,0.0122015437894065,0.028662838271874,1.14706209203573e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,28931,0.021739831409081,0.00418398629047237,0.0135392182797552,0.0299404445384068,2.05045430314277e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,28931,0.0177302348125676,0.00419936563249167,0.00949947817288397,0.0259609914522513,2.4275172874375e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,28931,0.021759984031494,0.0041947801557614,0.0135382149262016,0.0299817531367863,2.14692190805587e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,28931,0.00408339243644696,0.00424640903728421,-0.00423956927663009,0.012406354149524,0.336253227000457
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,28931,0.00491849158785239,0.00424189062130239,-0.00339561402990029,0.0132325972056051,0.246260146200836
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,28931,0.00610916242456112,0.00421561412938196,-0.00215344126902752,0.0143717661181498,0.147299573274596
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,28931,-0.000954519204446625,0.00412613589021766,-0.00904174554927323,0.00713270714037998,0.8170562778732
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,28931,-0.0058223471225076,0.00406949956584186,-0.0137985662715576,0.00215387202654244,0.152518980505987
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,28931,0.00442962423010656,0.00418010983570633,-0.00376339104787784,0.012622639508091,0.289294108653462
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,28931,0.00608422654060592,0.00428202284184903,-0.00230853822941817,0.01447699131063,0.155363386734965
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23495.Concentration of Large VLDL Particles,28931,-0.00188024681547679,0.00419387989136453,-0.0101002514025513,0.0063397577715977,0.653917612719933
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23496.Total Lipids in Large VLDL,28931,-0.00449589618461828,0.0041864524501463,-0.012701342986905,0.00370955061766847,0.282869515862598
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23497.Phospholipids in Large VLDL,28931,0.000374527999921853,0.00420801750494412,-0.00787318630976862,0.00862224230961232,0.929079798958524
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23498.Cholesterol in Large VLDL,28931,-0.00732587920545043,0.00410650716444493,-0.0153746332477625,0.000722874836861637,0.0744392753247738
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,28931,-0.0104323080085391,0.00403224974826647,-0.0183355175151414,-0.00252909850193686,0.00968027655876126
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,28931,-0.00451777403508626,0.00418836296279691,-0.0127269654421682,0.00369141737199568,0.280753171414266
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23501.Triglycerides in Large VLDL,28931,-0.00565885433183614,0.00420480206605616,-0.0139002663813062,0.00258255771763394,0.178375143771375
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,28931,-0.0276042279501881,0.0039407083697133,-0.0353280163548261,-0.01988043954555,2.52585659940668e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23503.Total Lipids in Medium VLDL,28931,-0.0238444469479059,0.00397556569603496,-0.0316365557121344,-0.0160523381836774,2.02444292779573e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23504.Phospholipids in Medium VLDL,28931,-0.0273610221179023,0.00393107000731228,-0.0350659193322343,-0.0196561249035702,3.47041633151889e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23505.Cholesterol in Medium VLDL,28931,-0.0364060534839175,0.00391504068592698,-0.0440795332283344,-0.0287325737395007,1.51412906224083e-20
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,28931,-0.0392839311634587,0.00395172688853851,-0.0470293158649942,-0.0315385464619232,3.00955175823841e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,28931,-0.030888351191068,0.00391419623691738,-0.0385601758154261,-0.02321652656671,3.09405530732514e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23508.Triglycerides in Medium VLDL,28931,-0.0120155912549415,0.00412840752909824,-0.020107270011974,-0.00392391249790891,0.00361165070625521
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23509.Concentration of Small VLDL Particles,28931,-0.0106124781640409,0.00402925002504504,-0.0185098082131292,-0.00271514811495263,0.00844653718592547
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23510.Total Lipids in Small VLDL,28931,-0.0140680726410787,0.00401350573073506,-0.0219345438733194,-0.00620160140883797,0.000456983697255931
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23511.Phospholipids in Small VLDL,28931,-0.0254905627983809,0.00394227743394141,-0.0332174265689061,-0.0177636990278557,1.02269780132367e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23512.Cholesterol in Small VLDL,28931,-0.0234539727698163,0.00393077667739035,-0.0311582950575014,-0.0157496504821312,2.44834997585455e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,28931,-0.0179875576308143,0.00394907315922218,-0.0257277410228898,-0.0102473742387389,5.26291508653811e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,28931,-0.0325515409240246,0.0039103562023181,-0.0402158390805681,-0.0248872427674811,8.8416181633618e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23515.Triglycerides in Small VLDL,28931,0.00339913192150426,0.00413975641369277,-0.00471479064933357,0.0115130544923421,0.411599115443302
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,28931,-0.00877701681810756,0.00396930679325047,-0.0165568581328785,-0.000997175503336644,0.0270282902078742
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,28931,-0.00709197792250524,0.00398308319127813,-0.0148988209774104,0.000714865132399888,0.0750006300982168
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,28931,-0.000422637752571893,0.00397773604291609,-0.00821900039668743,0.00737372489154365,0.915384080370694
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,28931,-0.0188754442515629,0.00402970915156148,-0.0267736741886233,-0.0109772143145024,2.82509969529847e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,28931,-0.0226484425029734,0.00405919024755062,-0.0306044553881726,-0.0146924296177742,2.43302608164591e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,28931,-0.00985992031207758,0.00398242471288947,-0.0176654727493409,-0.00205436787481421,0.0132973040394926
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,28931,0.012345723957853,0.00407183674556008,0.00436492393655527,0.0203265239791508,0.0024317111685572
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23523.Concentration of IDL Particles,28931,-0.0343372076900385,0.00394945447726888,-0.0420781384654855,-0.0265962769145915,3.67527707548523e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23524.Total Lipids in IDL,28931,-0.0454740549322581,0.00404580313471499,-0.0534038290762995,-0.0375442807882167,2.98932713917718e-29
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23525.Phospholipids in IDL,28931,-0.0403302238113058,0.00405236769059829,-0.0482728644848784,-0.0323875831377331,2.68741544850256e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23526.Cholesterol in IDL,28931,-0.0504988378444332,0.00405984179662127,-0.0584561277658109,-0.0425415479230555,1.98722341902575e-35
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23527.Cholesteryl Esters in IDL,28931,-0.0514395501207851,0.00405769372214583,-0.0593926298161909,-0.0434864704253793,9.92913873817009e-37
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23528.Free Cholesterol in IDL,28931,-0.0465444255826524,0.004059446831564,-0.0545009413725178,-0.038587909792787,2.28175282271415e-30
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23529.Triglycerides in IDL,28931,0.00780543560618698,0.00403416161461355,-0.000101521158455566,0.0157123923708295,0.0530203320198031
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23530.Concentration of Large LDL Particles,28931,-0.0410699327439505,0.00390634918421081,-0.0487263771450037,-0.0334134883428973,8.32191122834863e-26
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23531.Total Lipids in Large LDL,28931,-0.056527947767635,0.00393034671485415,-0.0642314273287491,-0.0488244682065208,9.6742112776411e-47
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23532.Phospholipids in Large LDL,28931,-0.0561679305758359,0.00392461632111783,-0.0638601785652269,-0.048475682586445,2.66276918820821e-46
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23533.Cholesterol in Large LDL,28931,-0.0590563741809518,0.00393876083956492,-0.066776345426499,-0.0513364029354046,1.25271951127281e-50
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,28931,-0.058254100774504,0.00392596187515978,-0.0659489860498172,-0.0505592154991908,1.26396990911808e-49
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23535.Free Cholesterol in Large LDL,28931,-0.0599735983139781,0.00398283205914529,-0.0677799491499029,-0.0521672474780533,4.77664654601357e-51
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23536.Triglycerides in Large LDL,28931,-0.00333214387541393,0.00403180550347561,-0.0112344826622261,0.00457019491139827,0.408547501290069
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23537.Concentration of Medium LDL Particles,28931,-0.0394356307662291,0.0039035542944042,-0.0470865971832613,-0.0317846643491969,5.90211613142184e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23538.Total Lipids in Medium LDL,28931,-0.0515139323908164,0.00389582206696337,-0.0591497436420646,-0.0438781211395682,8.45007499023329e-40
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23539.Phospholipids in Medium LDL,28931,-0.0531250351684157,0.00389185840643473,-0.0607530776450277,-0.0454969926918036,2.71953244253817e-42
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23540.Cholesterol in Medium LDL,28931,-0.0532005471866787,0.00389196568472124,-0.0608287999287323,-0.0455722944446251,2.0977563917433e-42
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,28931,-0.049438376690677,0.00390445318057971,-0.0570911049246133,-0.0417856484567408,1.20075241226529e-36
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,28931,-0.0607151391139609,0.00389553464408786,-0.0683503870163731,-0.0530798912115487,1.51561259700368e-54
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23543.Triglycerides in Medium LDL,28931,-0.00440018234122647,0.00407070700790021,-0.0123787680767109,0.00357840339425794,0.279733659280008
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23544.Concentration of Small LDL Particles,28931,-0.0319025389241746,0.00390520405189471,-0.0395567388658882,-0.024248338982461,3.22878101106552e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23545.Total Lipids in Small LDL,28931,-0.0469018532749664,0.0038955247079397,-0.0545370817025282,-0.0392666248474046,2.63287974324327e-33
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23546.Phospholipids in Small LDL,28931,-0.0491677963117061,0.00389328565897536,-0.0567986362032978,-0.0415369564201144,1.82720338387123e-36
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23547.Cholesterol in Small LDL,28931,-0.0488679459161674,0.00389158822379556,-0.0564954588348067,-0.0412404329975281,4.50142562381056e-36
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,28931,-0.0441666210491865,0.00390124324054745,-0.0518130578006595,-0.0365201842977135,1.19036038715524e-29
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23549.Free Cholesterol in Small LDL,28931,-0.0566594647570608,0.00389971525235073,-0.0643029066516682,-0.0490160228624533,1.16660261220521e-47
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23550.Triglycerides in Small LDL,28931,0.00446772343274841,0.00411726834796078,-0.00360212252925471,0.0125375693947515,0.277878287635609
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,28931,-0.00282262916180537,0.00458924159642149,-0.0118175426907915,0.00617228436718074,0.538524221271499
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23552.Total Lipids in Very Large HDL,28931,0.00383676918197194,0.00460939122939889,-0.00519763762764988,0.0128711759915938,0.405200858269137
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23553.Phospholipids in Very Large HDL,28931,0.0112986286837038,0.00459748895728651,0.00228755032742219,0.0203097070399853,0.0139940686317162
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23554.Cholesterol in Very Large HDL,28931,-0.00807644988878663,0.00461714381496745,-0.0171260517661228,0.000973151988549569,0.0802617510319917
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,28931,-0.0138031174533169,0.00466762681690108,-0.022951666014443,-0.00465456889219075,0.0031069512681259
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,28931,0.0110237050206369,0.00438296114178862,0.00243310118273121,0.0196143088585426,0.0119043196464665
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23557.Triglycerides in Very Large HDL,28931,0.0189301592751742,0.00397788122083824,0.0111335120823312,0.0267268064680171,1.95634450519156e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23558.Concentration of Large HDL Particles,28931,-0.024819539286255,0.00474750328234384,-0.0341246457196489,-0.015514432852861,1.7262350555019e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23559.Total Lipids in Large HDL,28931,-0.0209289519953945,0.00471582492820313,-0.0301719688546727,-0.0116859351361164,9.11231261683815e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23560.Phospholipids in Large HDL,28931,-0.0182604601881024,0.0046626681688711,-0.0273992897990898,-0.00912163057711507,9.01204887156518e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23561.Cholesterol in Large HDL,28931,-0.0271076829498884,0.00474541349463084,-0.0364086933993648,-0.0178066725004119,1.12488316223344e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,28931,-0.0295829302979319,0.00474521959044073,-0.0388835606951957,-0.020282299900668,4.6018722444418e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23563.Free Cholesterol in Large HDL,28931,-0.0181095042100869,0.00471906459219087,-0.0273588708107811,-0.00886013760939284,0.000124547351743923
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23564.Triglycerides in Large HDL,28931,0.0228006981427772,0.00406709184182925,0.0148291981327918,0.0307721981527625,2.08770086353529e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23565.Concentration of Medium HDL Particles,28931,-0.0487316874029537,0.00429392367391237,-0.057147777803822,-0.0403155970020855,8.67515656198192e-30
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23566.Total Lipids in Medium HDL,28931,-0.0455929858044578,0.00424152205952749,-0.0539063690411317,-0.0372796025677839,6.72013758872242e-27
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23567.Phospholipids in Medium HDL,28931,-0.0398338736075101,0.00419528479990903,-0.0480566318153318,-0.0316111153996884,2.3676571160574e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23568.Cholesterol in Medium HDL,28931,-0.0557743686213673,0.00432177456814037,-0.0642450467749224,-0.0473036904678121,5.34172706412691e-38
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,28931,-0.0567489843351237,0.00430698484006628,-0.0651906746216536,-0.0483072940485937,1.56754717044935e-39
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,28931,-0.0497035155372893,0.0043616930761834,-0.0582524339666088,-0.0411545971079699,5.10527061681898e-30
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23571.Triglycerides in Medium HDL,28931,0.0132645771721587,0.00402730960409691,0.00537105034812874,0.0211581039961886,0.000990117642992345
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23572.Concentration of Small HDL Particles,28931,-0.073643876185371,0.0038891757577928,-0.0812666606706449,-0.0660210917000971,1.75888253095835e-79
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23573.Total Lipids in Small HDL,28931,-0.060063956137526,0.0039250989248019,-0.0677571500301377,-0.0523707622449142,1.18314697231703e-52
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23574.Phospholipids in Small HDL,28931,-0.0530897682286364,0.00394755100232946,-0.0608269681932022,-0.0453525682640707,4.16074688612846e-41
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23575.Cholesterol in Small HDL,28931,-0.0759959837671262,0.00388902934314808,-0.0836184812796964,-0.068373486254556,1.72419034050586e-84
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,28931,-0.0772630383319125,0.00387633225580802,-0.0848606495532963,-0.0696654271105288,8.36147795858259e-88
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23577.Free Cholesterol in Small HDL,28931,-0.0608864470246032,0.00396621882235509,-0.0686602359164192,-0.0531126581327872,5.62295630522403e-53
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23578.Triglycerides in Small HDL,28931,0.0089953071592656,0.00421954294405795,0.000725002988912014,0.0172656113296192,0.0330300293570726
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27702,-0.000367827301145036,0.00401844842491037,-0.00824398621396936,0.00750833161167928,0.927068431117189
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27702,-0.0082228471435089,0.004071556288142,-0.0162030974682672,-0.000242596818750589,0.0434362419124926
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27702,-0.00270942357285025,0.00403215243841931,-0.0106124423521521,0.00519359520645159,0.501618175294362
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27702,-0.015618562515044,0.00411669052163935,-0.0236872759374571,-0.00754984909263083,0.000148578369410903
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27702,0.00676836474749133,0.00401296299969354,-0.001097042731908,0.0146337722268907,0.0916866978792588
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,28631,0.00916749427713367,0.00392634133592938,0.00147186525871208,0.0168631232955553,0.019557120980851
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,28631,-0.0139630804504461,0.00428032466146283,-0.0223525167869132,-0.00557364411397893,0.00110698310366805
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,28631,-0.0167838900451923,0.00427331019958829,-0.0251595780363853,-0.00840820205399924,8.59958295991597e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,28631,0.000169897546875174,0.00415746831091049,-0.00797874034250939,0.00831853543625974,0.967403305766594
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,28631,0.00779406342763266,0.00417537623932883,-0.000389674001451837,0.0159778008567172,0.0619574403934636
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,28926,0.0256804721280546,0.00415356467460613,0.0175394853658266,0.0338214588902826,6.38344801846266e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,28926,-0.00678197196946645,0.00403162990211125,-0.0146839665776045,0.00112002263867159,0.0925425866842079
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,28926,-0.00856630241931749,0.00417775307450228,-0.016754698445342,-0.000377906393293015,0.0403288664394221
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,28926,-0.00161640421172983,0.00394835154108993,-0.0093551732322661,0.00612236480880643,0.682258633142465
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,28926,-0.00252015709549572,0.00391018258259157,-0.0101841149573752,0.00514380076638376,0.519249006681767
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,28931,-0.0234125764743594,0.00411755430223483,-0.0314829829067397,-0.0153421700419792,1.31271169902096e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,28931,-0.02605834,0.004295356,-0.03447724,-0.01763945,1.322411e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,28931,-0.025352620797783,0.00432609499312014,-0.0338317669842985,-0.0168734746112675,4.66773357111822e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,28931,-0.0270818141134642,0.00419581619804697,-0.0353056138616363,-0.0188580143652921,1.10309373913021e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,28931,0.0257452017858407,0.00426084514977948,0.0173939452922729,0.0340964582794085,1.53810998204299e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,28931,-0.0451006588386108,0.00417303411213976,-0.0532798056984047,-0.0369215119788168,3.56958216328321e-27
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,28931,-0.0285004460348026,0.00406086494643629,-0.0364597413298177,-0.0205411507397874,2.29501228620875e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,28931,-0.0146289343749261,0.00397082142158286,-0.0224117443612285,-0.0068461243886237,0.000229923463259964
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,28931,-0.0441497360584096,0.00419746702781555,-0.0523767714329281,-0.0359227006838911,7.93123460992362e-26
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,28931,0.0338983188184308,0.00409712536279757,0.0258679531073476,0.041928684529514,1.35402703449138e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,28931,0.0558233311556056,0.00407451434547153,0.0478372830384814,0.0638093792727298,1.36787176939735e-42
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,28931,-0.0373754634992379,0.00426476533235969,-0.0457344035506629,-0.0290165234478129,1.98933685443708e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,28931,-0.0385982125891859,0.00430632471087191,-0.0470386090224948,-0.0301578161558769,3.34081252116809e-19
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,28931,-0.0224434190480529,0.00396138168906013,-0.0302077271586107,-0.014679110937495,1.47942151187457e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,28931,0.0286575193726478,0.00424008594135858,0.020346950927585,0.0369680878177107,1.41866519912101e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,28931,0.0446833260055463,0.0038884783937602,0.0370619083537763,0.0523047436573163,1.7012072630362e-30
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,28931,-0.0547329209785973,0.00408879046257431,-0.062746950285243,-0.0467188916719517,9.64354469705156e-41
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,28931,-0.0548038150862933,0.00405429959425734,-0.0627502422910377,-0.0468573878815489,1.64969323079665e-41
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,28931,-0.0219319954867518,0.00399093068413957,-0.0297542196276654,-0.0141097713458383,3.92980852184938e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,28931,0.0516864310845211,0.00417823278373945,0.0434970948283918,0.0598757673406504,4.63604729560975e-35
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,28931,0.0136549647353511,0.00392842927452427,0.00595524335728353,0.0213546861134187,0.00050982227367696
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,28931,-0.0679862181665318,0.00415359279873496,-0.0761272600520524,-0.0598451762810113,6.01997661668012e-60
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,28931,-0.0525727262773277,0.00389472922637974,-0.060206395561032,-0.0449390569936234,2.13266554094506e-41
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,28931,-0.0334504183585501,0.00430100154256869,-0.0418803813819847,-0.0250204553351155,7.65121048060254e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,28931,0.058761016413152,0.00411057844534713,0.0507042826602717,0.0668177501660324,3.37591787177284e-46
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,28931,-0.00106397935307407,0.00393707597969001,-0.00878064827326649,0.00665268956711835,0.786972872336084
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,28931,-0.0507403407578102,0.00396267274981748,-0.0585071793474525,-0.042973502168168,1.95389377239051e-37
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,28931,-0.0125672978624378,0.00401155403833953,-0.0204299437775833,-0.00470465194729233,0.00173334719268742
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,28931,-0.0338589475121046,0.00426885398952924,-0.0422259013315819,-0.0254919936926273,2.24056882952839e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,28931,0.0571641135836715,0.00402893840228406,0.0492673943151948,0.0650608328521483,1.5377702522375e-45
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,28931,0.00500613202837351,0.00395194436990855,-0.00273967893664724,0.0127519429933943,0.205254310170458
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,28931,-0.0419981757937783,0.00393021682282125,-0.0497014007665079,-0.0342949508210486,1.32756291763163e-26
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,28931,-0.00834464022992479,0.00394745241669306,-0.0160816469666432,-0.000607633493206387,0.0345297379337834
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,28931,-0.0384629714224453,0.00412124885057412,-0.0465406191695705,-0.03038532367532,1.10204942678559e-20
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,28931,0.0486174196467472,0.00413410020500317,0.040514583244941,0.0567202560485534,7.40670544918294e-32
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,28917,0.0356328180312324,0.00441980244967845,0.0269700052298627,0.0442956308326022,7.78787532445291e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,28917,-0.0478051432304041,0.00412127709622725,-0.0558828463390095,-0.0397274401217986,4.85108453122804e-31
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,28917,-0.0681751740296972,0.00394443330807218,-0.0759062633135187,-0.0604440847458757,1.34576608342387e-66
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,28917,0.0129822653637297,0.00465735427420167,0.00385385098629439,0.0221106797411649,0.00531549867485845
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,28917,0.0124906319601279,0.00435595979785785,0.00395295075632652,0.0210283131639293,0.00414052790149004
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,28931,0.0215038890797428,0.00433683188012333,0.013003698594701,0.0300040795647845,7.14661769733161e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,28931,-0.0339366397644783,0.00443998472732246,-0.0426390098300303,-0.0252342696989263,2.18081705636072e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,28931,-0.0398240617315042,0.00437108040562958,-0.0483913793265382,-0.0312567441364702,8.69058180741054e-20
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,28931,0.00304300757406081,0.00429446935070248,-0.00537415235331605,0.0114601675014377,0.478586168072632
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,28931,0.0375617126591446,0.00427891517482616,0.0291750389164854,0.0459483864018039,1.7488153577233e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,28931,0.0574238330975917,0.00437241804127026,0.048853893736702,0.0659937724584815,2.75347906667389e-39
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,28931,-0.0524353203831318,0.0043039865398154,-0.0608711340011699,-0.0439995067650936,4.64350365321654e-34
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,28931,-0.0471350132089986,0.00418905976475637,-0.0553455703479211,-0.0389244560700761,2.60715383893177e-29
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,28931,-0.0474194772119117,0.00457080048663812,-0.0563782461657224,-0.038460708258101,3.5883608046618e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,28931,0.0447381660433639,0.00421001169096249,0.0364865431290775,0.0529897889576504,2.50637830711968e-26
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,28931,0.0421382821466326,0.00402919141410782,0.0342410669749813,0.0500354973182839,1.49193332774044e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,28931,-0.0559670272007116,0.00401654232135436,-0.0638394501505661,-0.048094604250857,5.45386112228685e-44
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,28931,-0.0541769725504502,0.0039931385619469,-0.0620035241318661,-0.0463504209690342,8.38016618654904e-42
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,28931,-0.0105583322808837,0.00419621323993944,-0.018782910231165,-0.00233375433060242,0.0118695932676868
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,28931,0.044688277556631,0.00428350402252048,0.0362926096724909,0.0530839454407711,1.95208311501042e-25
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,49795,-0.00150807860331633,0.00339887093474927,-0.0081698656354249,0.00515370842879224,0.657261515462087
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,49795,-0.000852614875548051,0.00331716134506597,-0.00735425111187736,0.00564902136078126,0.797155537333207
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,46443,0.00422253909216827,0.00317788796244258,-0.00200612131421918,0.0104511994985557,0.183945253413455
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,46443,0.00114473165824094,0.00345762872012546,-0.00563222063320497,0.00792168394968685,0.740589934171692
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,46443,-0.00184208692932502,0.00340608261592893,-0.00851800885654572,0.00483383499789567,0.5886323626634
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,46443,0.00228685794896827,0.00312710884903173,-0.00384227539513391,0.00841599129307046,0.464598986956444
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24009.Traffic intensity on the nearest road,49795,-0.0247128380351135,0.0277914703812219,-0.0791841199823084,0.0297584439120815,0.373887089338105
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24010.Inverse distance to the nearest road,49795,0.00313856640296575,0.0029678686733754,-0.00267845619685003,0.00895558900278153,0.290281626849153
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24011.Traffic intensity on the nearest major road,49795,0.00365519247691594,0.0029698867410536,-0.00216578553554912,0.009476170489381,0.218421645784873
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24012.Inverse distance to the nearest major road,49795,-4.33857463079822e-05,0.0030166048295962,-0.00595593121231653,0.00586915971970057,0.988525030009651
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24013.Total traffic load on major roads,49795,-0.000477886184882824,0.0194502894717593,-0.038600453549531,0.0376446811797654,0.980398351680322
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24015.Sum of road length of major roads within 100m,49795,0.00109223631773574,0.0188907562696063,-0.0359336459706926,0.038118118606164,0.953893386533781
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,49795,-0.00263129295079129,0.00339254234162497,-0.00928067594037624,0.00401809003879366,0.437982424075438
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,49795,-0.00248186608144801,0.00338853611299234,-0.00912339686291299,0.00415966470001698,0.463909498090946
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,49795,-0.00257055301594161,0.00335283788731245,-0.00914211527507402,0.00400100924319079,0.443275563788448
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,49693,-0.000634334927107076,0.00329143170633813,-0.00708554107152982,0.00581687121731566,0.847176617958782
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24020.Average daytime sound level of noise pollution,49795,-0.00112654664750757,0.0029771853633333,-0.00696182995964084,0.0047087366646257,0.705140144756316
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24021.Average evening sound level of noise pollution,49795,-0.00116474970008044,0.00297709192350056,-0.00699984987014153,0.00467035046998065,0.695623441187606
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24022.Average night-time sound level of noise pollution,49795,-0.00113358024134239,0.00297720446545965,-0.00696890099364331,0.00470174051095854,0.703387985275587
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24023.Average 16-hour sound level of noise pollution,49795,-0.0011106427311038,0.00297717363205866,-0.00694590304993879,0.00472461758773118,0.709110792544017
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24024.Average 24-hour sound level of noise pollution,49795,-0.00112927105295445,0.00297715625731699,-0.00696449731729575,0.00470595521138685,0.70445781780935
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2405.Number of children fathered,22955,0.00694582981675084,0.0212102119592178,-0.034626185623316,0.0485178452568177,0.743311078554075
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44447,0.000827605914682812,0.00349567877000967,-0.00602392447453614,0.00767913630390176,0.812850954224025
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44447,0.00275383958335898,0.00316780370402694,-0.00345505567653382,0.00896273484325179,0.384676051165712
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24502.Water percentage, buffer 1000m",44447,-0.00450556800717768,0.003150931955644,-0.0106813946402399,0.00167025862588456,0.152748161494667
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44447,-0.000522657744856399,0.00329066446633818,-0.00697236009887923,0.00592704460916643,0.87380317311755
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44447,0.00150666991955654,0.00319427799441399,-0.00475411494949487,0.00776745478860796,0.637159123163656
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24505.Water percentage, buffer 300m",44447,-0.00197442127938975,0.00316926570572111,-0.00818618206260312,0.00423733950382363,0.533294200017521
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",50031,-0.000705111382768016,0.00333992160701558,-0.00725135773251855,0.00584113496698252,0.832797500361968
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24507.Natural environment percentage, buffer 300m",50031,0.000202258828506604,0.00314123455510282,-0.00595456089949492,0.00635907855650813,0.948661284094585
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24508.Distance (Euclidean) to coast,50031,-0.000198608055663237,0.00298743466933057,-0.00605398000755116,0.00565676389622469,0.94699504012148
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,10988,-0.0189083544192177,0.0286172013719334,-0.0749980691082071,0.0371813602697717,0.508796863627615
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2704.Years since last cervical smear test,20652,0.0269030260888888,0.0208955714036326,-0.0140522938622311,0.0678583460400086,0.197934875567811
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2714.Age when periods started (menarche),26342,0.0205271877771536,0.0175708773619066,-0.0139117318521834,0.0549661074064905,0.242716279513099
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2734.Number of live births,27160,0.0660764929288884,0.0168608983642802,0.0330291321348992,0.0991238537228775,8.91651251758152e-05
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2744.Birth weight of first child,21537,-0.0185323099258342,0.0188310805901996,-0.0554412278826254,0.0183766080309571,0.325060613150628
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2754.Age at first live birth,18350,-0.0047017568460964,0.00513093904982317,-0.0147583973837498,0.00535488369155701,0.35949327152276
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2764.Age at last live birth,18299,-0.00163006154275156,0.00495602780918585,-0.0113438760487558,0.0080837529632527,0.742231381068937
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2794.Age started oral contraceptive pill,20841,0.00428901911271344,0.00557784722709291,-0.00664356145238866,0.0152215996778155,0.441938791676786
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2804.Age when last used oral contraceptive pill,18905,-0.00679401232405057,0.00484495940057728,-0.016290132749182,0.0027021081010809,0.160846685508701
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2867.Age started smoking in former smokers,12342,-0.00707401528799761,0.00611097943763145,-0.0190515349857553,0.00490350440976003,0.247053378056901
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",19195,-0.0176388241928011,0.0248843323418336,-0.0664121155827949,0.0311344671971927,0.478437025404642
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,19186,0.0143604321835687,0.0275528951351183,-0.039643242281263,0.0683641066484005,0.602236932054924
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,19223,-0.00566524135782178,0.0283741474023732,-0.0612785702664733,0.0499480875508298,0.841746984085895
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",19169,-0.0289257215444131,0.0276222688201362,-0.08306536843188,0.0252139253430538,0.295025874589891
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28739.Difficulty with standing for long periods,19241,0.0495882935366022,0.0241442589034925,0.00226554608575691,0.0969110409874474,0.0400052808996949
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28740.Difficulty with taking care of household responsibilities,19285,0.0756083003836919,0.0270398775443427,0.0226101403967802,0.128606460370604,0.00517621785568484
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28741.Difficulty learning a new task,19129,0.0499442618989069,0.0304837943656534,-0.0098039750577737,0.109692498855588,0.101357385214398
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28742.Difficulty with joining in community activities,18429,0.0115366233962082,0.0305599682597615,-0.0483609143929244,0.0714341611853408,0.705800692866082
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28743.Difficulty with being emotionally affected by health problems,19158,0.0153409404464741,0.0260195294312405,-0.0356573372387573,0.0663392181317054,0.55547029784276
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,19285,0.0237009398722199,0.0370026623317963,-0.0488242782981008,0.0962261580425406,0.521842302834927
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,11716,0.0475661113203286,0.0275133363874564,-0.00636002799908599,0.101492250639743,0.0838644063942444
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2897.Age stopped smoking,12350,0.016682948691145,0.00638617387105109,0.00416604790388485,0.0291998494784051,0.00900300085600673
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,17213,-0.00590441529848188,0.0107459751220227,-0.0269665265376464,0.0151576959406826,0.582701295612273
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,17213,0.00566402826884193,0.0117032572238481,-0.0172743558899003,0.0286024124275841,0.628413148131359
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,17213,0.023996774638123,0.0388771001227414,-0.0522023416024502,0.100195890878696,0.537079969878181
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,17213,-0.0192717228278561,0.0403155543179761,-0.0982902092910893,0.0597467636353771,0.632640605877654
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,17213,0.0817272978622575,0.0447902028944728,-0.00606149981090905,0.169516095535424,0.0680683222901383
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,17213,0.0258607418457989,0.0381422510680163,-0.048898070247513,0.100619553939111,0.497775900155263
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,17213,0.0206637170758439,0.0168933245840703,-0.012447199108934,0.0537746332606218,0.221275340452471
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,17213,0.0367071768211843,0.0307121888233931,-0.0234887132726661,0.0969030669150348,0.232025776007389
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29002.Recent lack of interest or pleasure in doing things,17100,-0.0227792525332349,0.0285629641575475,-0.0787626622820281,0.0332041572155582,0.425165920816399
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29003.Recent feelings of depression,17085,-0.0457167848491756,0.0276721732804814,-0.099954244478919,0.00852067478056786,0.0985355996098931
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",17107,0.0100789595654891,0.0223814353362434,-0.0337886536935479,0.053946572824526,0.652480548498718
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29005.Recent feelings of tiredness or low energy,17116,0.0423127018423188,0.0225126047617455,-0.0018120034907024,0.08643740717534,0.0601916607904362
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29006.Recent poor appetite or overeating,17129,-0.0109212600530687,0.0312761236946787,-0.072222462494639,0.0503799423885016,0.726952159493433
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29007.Recent feelings of inadequacy,17060,0.00640934183120317,0.0300470864061567,-0.052482947524864,0.0653016311872704,0.831087781796319
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29008.Recent trouble concentrating on things,17126,-0.0143992214620143,0.0297009532330203,-0.072613089798734,0.0438146468747054,0.627819667904542
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29009.Recent changes in speed or amount of moving or speaking,17111,0.0162407650527348,0.0523000168281385,-0.0862672679304168,0.118748798035886,0.756161141773844
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29010.Recent thoughts of suicide or self-harm,17026,0.0672258631123098,0.0581460680154251,-0.0467404301979235,0.181192156422543,0.247634029569591
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#0.Substances taken for depression_None of options listed,15797,0.00415291459567824,0.0204319947274083,-0.035893795070042,0.0441996242613985,0.838937982669893
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),15797,-0.0321397611485995,0.0396385720913218,-0.10983136244759,0.0455518401503911,0.417481068635474
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),15797,-0.034798014404337,0.0204838073268569,-0.0749462767649765,0.00535024795630254,0.0893754548711441
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),15797,-0.0894132620440479,0.0607721897738346,-0.208526754000764,0.0297002299126678,0.141233769004761
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),15797,-0.0615850392698584,0.0383344505835564,-0.136720562413629,0.0135504838739121,0.108179836361267
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),15797,-0.107208592515317,0.0410867680451082,-0.187738657883729,-0.0266785271469045,0.00908075173821581
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),15797,-0.0384410436753483,0.0453900181325469,-0.12740547921514,0.0505233918644437,0.397060789134836
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),15797,-0.0577900624550021,0.0529750604028335,-0.161621180844556,0.0460410559345515,0.275337120405301
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),15797,0.00334067453517415,0.0400512171979862,-0.0751597111728788,0.0818410602432271,0.933526545373219
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,15797,-0.0222565594443662,0.0200919741789915,-0.0616368288351896,0.0171237099464572,0.267993666906723
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,15797,-0.0343662922048645,0.031398111128574,-0.0959065900168696,0.0271740056071406,0.273737658295446
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,15797,-0.128820692323856,0.0491148339198632,-0.225085766806788,-0.0325556178409241,0.00872822284686169
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,15797,-0.0336400289028698,0.0629101847264557,-0.156943990966723,0.0896639331609835,0.592843382656003
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,15797,-0.0346180258682813,0.0393373976475184,-0.111719325257417,0.0424832735208548,0.378857340879181
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,15797,-0.147455054152653,0.0640406724495896,-0.272974772153849,-0.0219353361514576,0.0213187015237053
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,15797,-0.0998207362495539,0.0618274691093892,-0.221002575703957,0.0213611032048489,0.106437999170575
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,15797,-0.00745504668988423,0.0340957290874851,-0.0742826757013551,0.0593725823215866,0.8269251730355
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,15797,-0.0401038940570414,0.0329630260471813,-0.104711425109517,0.0245036369954339,0.223762203852735
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,15797,-0.0845410592386774,0.0467909056327827,-0.176251234278931,0.0071691158015766,0.0708150025279778
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29058.Recent feelings or nervousness or anxiety,16852,0.00669758040539752,0.0262397018279004,-0.0447322351772872,0.0581273959880822,0.798536179050555
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29059.Recent inability to stop or control worrying,16870,-0.00517616285076172,0.0273183739047518,-0.0587201757040752,0.0483678500025518,0.849722428616179
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29060.Recent worrying too much about different things,16859,0.0200217300011658,0.0251348466765305,-0.0292425694848341,0.0692860294871657,0.425710527288329
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29061.Recent trouble relaxing,16861,-0.0187474772737733,0.0265420615568576,-0.0707699179252141,0.0332749633776676,0.479992172993499
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29062.Recent restlessness,16881,0.079038854085768,0.038087102816771,0.0043881325648969,0.153689575606639,0.0379819134951474
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29063.Recent easy annoyance or irritability,16835,-0.0284527360369621,0.0268676473363902,-0.0811133248162869,0.0242078527423628,0.289616725313189
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29064.Recent feelings of foreboding,16827,-0.000361969192126617,0.030754747384817,-0.0606412740663679,0.0599173356821147,0.990609623176435
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,15797,-0.0379786920164692,0.0215114885704523,-0.0801412096145557,0.00418382558161726,0.0774978622195914
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,15797,-0.0511621468280632,0.0360959345622459,-0.121910178570065,0.0195858849139386,0.156387621261346
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',15797,-0.0179341242201685,0.046493999549398,-0.109062363336989,0.0731941148966516,0.699701940231688
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,15797,-0.00611631589681349,0.0497843998495028,-0.103693739601839,0.0914611078082121,0.902222634419405
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#2.Symptoms of panic attack_Sweating,15797,-0.022372574406532,0.0324832299359788,-0.0860397050810505,0.0412945562679865,0.490995577299185
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,15797,-0.0531936145238682,0.0349157256420084,-0.121628436782205,0.0152412077344682,0.127657229282375
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,15797,0.0586487914035222,0.0351412876183186,-0.0102281323283821,0.127525715135427,0.0951485925825556
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,15797,-0.0502855789437447,0.0323717427512843,-0.113734194736262,0.0131630368487725,0.120352714818603
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,15797,-0.0938880694594949,0.0435843173286484,-0.179313331423646,-0.00846280749534399,0.0312418581462569
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29076.Felt loved as a child,16800,-0.0129039271578292,0.0233712530269156,-0.0587115830905838,0.0329037287749255,0.580867895221898
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29077.Physically abused by family as a child,16824,0.011069441686627,0.0313301882553768,-0.0503377272939116,0.0724766106671656,0.723856344533104
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29078.Felt hated by family member as a child,16797,-0.00111586869256606,0.0317005899713371,-0.0632490250363868,0.0610172876512547,0.971920481570657
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29079.Sexually molested as a child,16674,-0.0119875840182126,0.0423033762964573,-0.094902201559269,0.0709270335228438,0.776895362413193
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29080.Someone to take to doctor when needed as a child,16766,-0.038977866595347,0.0340644558542647,-0.105744200069706,0.0277884668790119,0.252541035017334
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,16804,0.064179891593038,0.0443352935521741,-0.0227172837692232,0.151077066955299,0.147746861794841
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29082.Belittlement by partner or ex-partner as an adult,16695,0.0211756203900404,0.0344847403807021,-0.0464144707561357,0.0887657115362165,0.539185573259006
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29083.Physical violence by partner or ex-partner as an adult,16817,0.000796523662604763,0.0386646251579386,-0.0749861416469549,0.0765791889721644,0.983564316944485
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,16767,0.0315515941968309,0.0545010280474115,-0.0752704207760956,0.138373609169757,0.562652683293589
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,16769,0.0597444173672111,0.0522503453790068,-0.0426662595756422,0.162155094310064,0.252877989346802
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29086.Experienced a violent or sexual assault,16817,-0.0509042582488022,0.0436500293063321,-0.136458315689213,0.0346497991916088,0.243553904540152
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29087.Experienced a life-threatening injury or illness,16817,0.0527750175730317,0.0274278344987511,-0.000983538044520428,0.106533573190584,0.0543537978082308
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29088.Experienced a marital separation or divorce,16825,0.0141104308610483,0.0254337118907512,-0.035739644444824,0.0639605061669207,0.57904402602472
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29089.Experienced the death of a spouse or partner,16845,-0.0207202567981611,0.034384968797729,-0.08811479564171,0.0466742820453879,0.546785366053978
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,16821,0.0249012456825598,0.0319516994637329,-0.0377240852663567,0.0875265766314762,0.435790280237083
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29091.Frequency of drinking alcohol,16826,-0.0483110054628529,0.0209880926305323,-0.0894476670186963,-0.00717434390700955,0.0213569693687394
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,15012,-0.0419924850985117,0.0241612878969631,-0.0893486093765594,0.00536363917953591,0.082230126163281
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,15048,-0.0766592336237263,0.0243996406688361,-0.124482529334645,-0.0288359379128075,0.00168228213963221
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29104.Ever used cannabis,16814,-0.049184068984159,0.0300918249093784,-0.108164045806541,0.00979590783822273,0.102179749331168
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29108.Ever thought that life not worth living,16732,-0.00956993403481633,0.0266252939289381,-0.0617555101355351,0.0426156420659024,0.719277844977848
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29109.Ever contemplated self-harm,16776,-0.0207898723408605,0.035977577614875,-0.0913059244660155,0.0497261797842945,0.563368857688972
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29111.Ever self-harmed,16802,0.0176056606153622,0.0579272679868489,-0.0959317846388617,0.131143105869586,0.761187276210076
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,16798,-0.0588169468031075,0.038079582213444,-0.133452927941458,0.0158190343352427,0.122466832227476
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,17094,-0.0502936408263207,0.0456286160616395,-0.139725728307134,0.0391384466544927,0.270373305570199
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,17094,-0.0456648371275477,0.035075084716427,-0.114412003171745,0.0230823289166492,0.19296243433216
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,17094,-0.0288523253544107,0.0377936386796042,-0.102927857166435,0.0452232064576135,0.445224987815864
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,17094,-0.0283873770175691,0.0508226961601661,-0.127999861491495,0.0712251074563564,0.576471357422592
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,16783,-0.0437802367625464,0.023778476613011,-0.0903860509240479,0.00282557739895517,0.0656141872560352
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X29153.Pain or discomfort today,16808,0.0319621355434226,0.0224421577089155,-0.0120244935660519,0.075948764652897,0.154406980849067
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29154.Anxiety or depression today,16808,0.00015833932260025,0.0280710409440532,-0.054860900927744,0.0551775795729445,0.995499491801845
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29166.Frequency of confiding in someone close,16390,0.0286856772141056,0.0219654767843842,-0.0143666572832874,0.0717380117114987,0.191590034135348
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,16753,0.0012458807849855,0.0108789035995855,-0.020076770270202,0.022568531840173,0.908824872125706
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,16753,-0.00869416861661312,0.0109181177717583,-0.0300936794492593,0.0127053422160331,0.425865176653697
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,16753,-0.0162711286195074,0.0135830041610988,-0.0428938167752611,0.0103515595362463,0.230971537038818
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,16753,0.0127682830874139,0.014742740658343,-0.0161274886029384,0.0416640547777661,0.386462787042348
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,16753,-0.0672531340393812,0.0237230603820604,-0.11375033238822,-0.0207559356905428,0.00458911322856256
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,16753,-0.00591086855930713,0.0112447174551493,-0.0279505147713998,0.0161287776527856,0.599133254106637
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,16752,0.00644295444168483,0.0122152736239345,-0.0174989818612267,0.0303848907445964,0.597887644933535
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,16752,-0.000737326962818072,0.0178577249208228,-0.0357384678076307,0.0342638138819946,0.967066023423644
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,16752,-0.0359136493018061,0.0274945502575208,-0.0898029678065469,0.0179756692029347,0.19149919123821
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,16752,0.0220265086086193,0.024705074469846,-0.0263954373522789,0.0704484545695175,0.37263181506962
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,16752,-0.0811504631985272,0.0365128077375319,-0.15271556636409,-0.00958536003296472,0.0262614614796225
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,16752,-0.0157844657191713,0.0175651518563414,-0.0502121633576004,0.0186432319192578,0.368865936690518
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29171.Frequency of feeling 'in tune' with people,16469,-0.00312003445864045,0.0272853151405271,-0.0565992521340735,0.0503591832167926,0.908962943980229
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29172.Freuency of feeling that lacks companionship,16689,0.0301955364907771,0.0250583559923814,-0.0189188412542904,0.0793099142358445,0.228217052741259
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29173.Frequency of feeling left out,16603,-0.00852570679255725,0.0259417163033796,-0.0593714707471813,0.0423200571620668,0.742425514706557
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29174.Frequency of feeling isolated from others,16662,-0.0123073378845105,0.0267969277920607,-0.0648293163569495,0.0402146405879285,0.6460379023368
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29175.Tendency to bounce back quickly after hard times,16786,-0.00107351887655464,0.0221249237025458,-0.0444383693335445,0.0422913315804352,0.961301770174309
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29176.Ability to make it through stressful events,16786,0.00889326969644626,0.0214541983629522,-0.03315695909494,0.0509434984878325,0.678496052428691
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29177.Quick recovery from stressful events,16786,0.00496913226288667,0.0218851376986421,-0.0379257376264518,0.0478640021522251,0.820383660276028
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29178.Hard to snap back when something bad happens,16786,0.00125739598201251,0.0215564098633675,-0.0409931673501878,0.0435079593142129,0.953486075189194
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29179.Comes through difficult times with little trouble,16786,0.0147707464841825,0.0218583435496477,-0.0280716068731271,0.0576130998414921,0.499209550740266
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29180.Tendency to take a long time to get over setbacks,16786,0.00306116137647833,0.021693568531938,-0.0394582329461202,0.0455805556990769,0.887785397177173
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29181.General happiness,16688,-0.00974176185668508,0.0225601428370999,-0.0539596418174009,0.0344761181040308,0.665882950557176
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29182.Belief that own life is meaningful,16496,0.0270148993640377,0.0223221752221359,-0.0167365640713487,0.0707663627994241,0.226209155499147
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,11235,0.00376030704596623,0.0262019653205299,-0.0475955449822723,0.0551161590742048,0.885888092504993
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2946.Father's age,11008,-0.0120749753612658,0.00947188462614966,-0.0306398692285191,0.00648991850598759,0.202398877202413
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2966.Age high blood pressure diagnosed,12570,-0.0216410810310997,0.00756239191254453,-0.036463369179687,-0.0068187928825124,0.00422109888998362
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30000.White blood cell (leukocyte) count,48899,0.00326105383270981,0.00316109742416687,-0.00293469711865724,0.00945680478407687,0.302254899311021
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,48900,-0.00673788614765027,0.00353130577864552,-0.0136592454737955,0.000183473178494949,0.0563914056801339
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30020.Haemoglobin concentration,48900,-0.007979808651942,0.00377860370499455,-0.0153858719137313,-0.000573745390152688,0.034705184469465
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30030.Haematocrit percentage,48900,-0.00639057873280265,0.00369088929358508,-0.0136247217482294,0.000843564282624108,0.0833784011750536
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30040.Mean corpuscular volume,48900,0.00341047557448408,0.00311625485503078,-0.00269738394137625,0.00951833509034441,0.273778468251662
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30050.Mean corpuscular haemoglobin,48899,0.00111416669441795,0.00312740782700806,-0.00501555264651785,0.00724388603535375,0.721648265801766
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,48899,-0.00522016947104777,0.00305208445218406,-0.0112022549973285,0.000761916055232987,0.087205286170653
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,48900,0.0230453429412388,0.00304829600647457,0.0170706827685486,0.0290200031139289,4.09858959711305e-14
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30080.Platelet count,48900,-0.0136533087989961,0.00312014467806592,-0.0197687923680053,-0.00753782522998687,1.21206210515149e-05
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30090.Platelet crit,48900,-0.00280550687927032,0.0031899750442585,-0.00905785796601698,0.00344684420747633,0.379147497643402
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,48900,0.0206715798370144,0.00299138744290196,0.0148084604489266,0.0265346992251023,4.8931070497315e-12
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30110.Platelet distribution width,48900,0.0215167798895979,0.00302629673857638,0.0155852382819882,0.0274483214972076,1.1768208157158e-12
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30120.Lymphocyte count,48824,-0.00631740749353524,0.00311163382072858,-0.0124162097821632,-0.000218605204907229,0.0423361228540561
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30130.Monocyte count,48824,0.0311894098338749,0.00313469255000989,0.0250454124358555,0.0373334072318943,2.6608009244899e-23
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30140.Neutrophill count,48824,-0.000890379733228573,0.00312229299143132,-0.00701007399643396,0.00522931452997681,0.775516231629171
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30150.Eosinophill count,48824,0.0313065595150036,0.00303660627327049,0.0253548112193934,0.0372583078106137,6.75482142823033e-25
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30160.Basophill count,48824,0.0183779322409982,0.0140310646343387,-0.00912295444230577,0.0458788189243021,0.190268611974532
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30170.Nucleated red blood cell count,48824,0.0657459152961714,0.0658835982963671,-0.0633859373647081,0.194877767957051,0.31832784855759
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30180.Lymphocyte percentage,48825,-0.0101447039208078,0.00305836238154157,-0.0161390941886293,-0.00415031365298638,0.000910436916561361
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30190.Monocyte percentage,48825,0.0316803354880966,0.00309701973785754,0.0256101768018958,0.0377504941742973,1.55187059297345e-24
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30200.Neutrophill percentage,48825,-0.00671979974073281,0.00302723326074412,-0.0126531769317913,-0.000786422549674326,0.0264381050111451
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30210.Eosinophill percentage,48825,0.0305370792879982,0.00300473258507135,0.0246478034212583,0.036426355154738,3.06617580572468e-24
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30220.Basophill percentage,48825,0.00529584319036387,0.00299537303572368,-0.000575087959654543,0.0111667743403823,0.0770658288203735
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30230.Nucleated red blood cell percentage,48823,0.0701106490214537,0.0660060363121701,-0.0592611821503998,0.199482480193307,0.288156775569818
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30240.Reticulocyte percentage,48046,0.00444026876115523,0.00322822712045961,-0.00188705639494561,0.0107675939172561,0.16899802956697
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30250.Reticulocyte count,48046,0.00309925871359452,0.00329749793984327,-0.00336383724849828,0.00956235467568733,0.347282855839067
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30260.Mean reticulocyte volume,48046,0.0179409463894112,0.00307204620468862,0.0119197358282216,0.0239621569506009,5.25159304626971e-09
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30270.Mean sphered cell volume,48046,0.00731688958436874,0.00310057962419362,0.00123975352094925,0.0133940256477882,0.0182865124674259
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30280.Immature reticulocyte fraction,48046,0.00140686948238691,0.00322634057795339,-0.00491675805040173,0.00773049701517555,0.662797089187905
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30290.High light scatter reticulocyte percentage,48046,0.0044650916176486,0.0032969967326596,-0.00199702197836422,0.0109272052136614,0.175650061207675
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30300.High light scatter reticulocyte count,48046,0.00350569283123555,0.00334702258612251,-0.00305447143756458,0.0100658571000357,0.294917458073575
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30500.Microalbumin in urine,15910,0.0497885629162912,0.00537549534173272,0.039252592046495,0.0603245337860873,2.25483096473399e-20
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,48993,-0.00422347757845803,0.00325386682739902,-0.0106010565601601,0.00215410140324406,0.194297836638973
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30520.Potassium in urine,48892,-0.0116664268590538,0.00303472650248329,-0.0176144908039211,-0.00571836291418658,0.000121045525491436
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30530.Sodium in urine,48879,-0.00970888648103947,0.00316917445055924,-0.0159204684041356,-0.00349730455794336,0.00218855409955483
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30600.Albumin,44053,-0.0616347377900806,0.00326553101799499,-0.0680351785853508,-0.0552342969948104,3.81179666132433e-79
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30610.Alkaline phosphatase,48074,0.0666509900867854,0.00312796239028688,0.0605201838018231,0.0727817963717476,2.78387578260327e-100
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30620.Alanine aminotransferase,48069,0.019913207013918,0.00331949678551548,0.0134069933143077,0.0264194207135283,2.00120284130699e-09
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30630.Apolipoprotein A,43781,-0.0629019881374686,0.00357364237808825,-0.0699063271985216,-0.0558976490764156,4.1439392442578e-69
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30640.Apolipoprotein B,47813,-0.037513539212409,0.00303083474764161,-0.0434539753177866,-0.0315731031070314,3.9265182395954e-35
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30650.Aspartate aminotransferase,47926,0.0413001625306065,0.0031495888589039,0.0351269683671549,0.0474733566940582,3.24674953922416e-39
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30660.Direct bilirubin,40784,0.0149927337256659,0.00341744443448071,0.00829454263408369,0.0216909248172481,1.15150015912099e-05
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30670.Urea,48054,0.0217492265780533,0.0032076722194465,0.0154621890279381,0.0280362641281684,1.21245012843412e-11
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30680.Calcium,44052,-0.0205185875950436,0.00317198850736071,-0.0267356850694706,-0.0143014901206166,9.98947272350503e-11
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30690.Cholesterol,48085,-0.0491284337636781,0.00307605252697968,-0.0551574967165582,-0.0430993708107979,2.84667871891707e-57
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30700.Creatinine,48068,0.0352100459498762,0.00372039874886896,0.027918064402093,0.0425020274976593,3.09132700525623e-21
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30710.C-reactive protein,47939,0.0401425309052368,0.0034030294845685,0.0334725931154826,0.0468124686949911,4.52752062303815e-32
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30720.Cystatin C,48087,0.111744583889894,0.00352674772942755,0.104832158340217,0.118657009439572,4.45909804990097e-218
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30730.Gamma glutamyltransferase,48064,0.01885852580003,0.00338606870568878,0.01222183113688,0.02549522046318,2.56914790322392e-08
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30740.Glucose,43999,0.0240897424425828,0.00326220951829845,0.0176958117867178,0.0304836730984477,1.55744871350055e-13
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47811,0.0239536614737735,0.00329221401175406,0.0175009220107356,0.0304064009368115,3.49512241228257e-13
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30760.HDL cholesterol,44023,-0.0681798843529135,0.00373154934988433,-0.0754937210786868,-0.0608660476271402,2.64458309226928e-74
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30770.IGF-1,47836,-0.0328549100647764,0.00317620885345442,-0.039080279417547,-0.0266295407120057,4.73188474034291e-25
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30780.LDL direct,47981,-0.0402643544756377,0.00303720545417496,-0.0462172771658206,-0.0343114317854548,4.83234722584306e-40
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30790.Lipoprotein A,38422,-0.00688206376563516,0.00339601374309173,-0.0135382507020949,-0.000225876829175375,0.0427192050812909
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30810.Phosphate,43951,-0.00355625369583334,0.00328625656489274,-0.00999731656302311,0.00288480917135643,0.279187608875401
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30830.SHBG,43642,0.0131851601310892,0.00378197893220014,0.00577248142397688,0.0205978388382014,0.000490209977240802
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30840.Total bilirubin,47896,0.00103044714581304,0.00323164967490706,-0.0053035862170048,0.00736448050863088,0.749833286943789
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30850.Testosterone,43428,0.00204428328796282,0.00529224168655644,-0.0083285104176878,0.0124170769936134,0.699291739936586
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30860.Total protein,44020,0.0583691444868652,0.00321499269351168,0.0520677588075823,0.0646705301661481,2.16287972093213e-73
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30870.Triglycerides,48051,0.0106880430321217,0.00330700213432609,0.00420631884884255,0.0171697672154008,0.00123034345165704
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30880.Urate,48019,0.0376165195664388,0.00380448667228995,0.0301597256887505,0.0450733134441271,4.96643506625716e-23
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30890.Vitamin D,45900,-0.0074424956302725,0.00342938911797322,-0.0141640983015,-0.000720892959044982,0.0299960294120034
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3137.Number of measurements made,45696,0.0145080576018588,0.0161710046632228,-0.017187111538058,0.0462032267417756,0.369635665777014
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3143.Ankle spacing width,28597,0.00292625100775106,0.00538531356341448,-0.00762896357654131,0.0134814655920434,0.586875073590485
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",28595,-0.0130435893942854,0.00414822398491013,-0.0211741084047092,-0.00491307038386152,0.00166609966579824
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3146.Speed of sound through heel,28597,-0.011985844823657,0.0040087008301243,-0.0198428984507006,-0.00412879119661337,0.00279253824977422
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",28597,-0.0128972260148503,0.00405033677393414,-0.0208358860917612,-0.00495856593793938,0.00145292508297678
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3148.Heel bone mineral density (BMD),28575,-0.0134793910126845,0.00405722609008426,-0.0214315541492496,-0.00552722787611933,0.000893852799774792
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X3526.Mother's age at death,30074,-0.003106705,0.004011639,-0.01096952,0.004756108,0.4386869
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X3581.Age at menopause (last menstrual period),15537,-0.0101526698176814,0.00542307488053557,-0.0207818965835311,0.00047655694816829,0.0612082060247631
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",9936,-0.00693066952330364,0.00698959913812817,-0.0206302838340349,0.00676894478742757,0.321432019200942
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4100.Ankle spacing width (left),16203,0.0217520143838559,0.00733540227074674,0.00737462593319232,0.0361294028345195,0.00302782475983352
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4101.Heel broadband ultrasound attenuation (left),16199,-0.0220559517548327,0.00564830113334819,-0.0331266219761952,-0.0109852815334703,9.46537792472061e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4103.Speed of sound through heel (left),16203,-0.0238279859593,0.00546352039743958,-0.0345364859382816,-0.0131194859803185,1.30097843738027e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",16203,-0.0241536904615241,0.00551914649641062,-0.034971217594489,-0.0133361633285593,1.21441302872749e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4105.Heel bone mineral density (BMD) (left),16191,-0.0241264140949122,0.00552536145438843,-0.0349561225455135,-0.0132967056443109,1.27045491728539e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",16203,-0.024161951139889,0.00551915973144379,-0.0349795042135188,-0.0133443980662592,1.20617314347306e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4119.Ankle spacing width (right),16192,0.0189666356804067,0.00722973717453732,0.00479635081831357,0.0331369205424999,0.00871336105180143
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4120.Heel broadband ultrasound attenuation (right),16191,-0.0165921077318277,0.00567798149812218,-0.0277209514681471,-0.00546326399550821,0.00348066874240482
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4122.Speed of sound through heel (right),16192,-0.0190318686701297,0.00548137594061615,-0.0297753655137374,-0.00828837182652208,0.00051775842447251
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",16192,-0.0187860476524872,0.00554314395992917,-0.0296506098139483,-0.007921485491026,0.000703000227201303
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4124.Heel bone mineral density (BMD) (right),16178,-0.0185214308631745,0.00554917271079145,-0.0293978093763257,-0.00764505235002324,0.000846679029814334
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",16192,-0.0187856745388539,0.00554315084065336,-0.0296502501865345,-0.00792109889117329,0.000703183473643699
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4194.Pulse rate,16833,0.0166855375544882,0.00526373902819905,0.00636860905921802,0.0270024660497583,0.00152763620463256
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4195.Pulse wave reflection index,16833,-0.00344639090283856,0.00540422717659433,-0.0140386761689635,0.00714589436328634,0.523663784361839
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4196.Pulse wave peak to peak time,16822,-0.0110139027369064,0.00537175059047861,-0.0215425338942444,-0.000485271579568278,0.0403469647625444
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4198.Position of the pulse wave peak,16833,0.0101117591580536,0.00541346988139255,-0.000498641809475836,0.020722160125583,0.061794964182559
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4199.Position of pulse wave notch,16833,0.0119546132198796,0.00526476254044282,0.00163567864061167,0.0222735477991475,0.0231786890119795
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4200.Position of the shoulder on the pulse waveform,16833,0.0164369750490905,0.00544539149868389,0.00576400771167006,0.0271099423865109,0.00254400527872581
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4269.Number of triplets attempted (left),16524,0.178158610367064,0.0660255696718883,0.0487484938101628,0.307568726923965,0.00697597585980866
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4270.Volume level set by participant (left),16350,0.0151018457954688,0.0212585425456353,-0.0265648975939763,0.056768589184914,0.477472764171237
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4276.Number of triplets attempted (right),16526,0.119454284868317,0.0652039707762622,-0.00834549785315679,0.247254067589791,0.0669680421776067
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4277.Volume level set by participant (right),16330,0.0279452077735248,0.021319006096509,-0.0138400441756329,0.0697304597226824,0.189939759655938
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X4288.Time to answer,16874,-0.00324300502665209,0.00607532460105143,-0.0151506412447129,0.00866463119140872,0.593487320695813
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X4290.Duration screen displayed,16874,0.0139116471146224,0.00554608204700839,0.00304132630248592,0.0247819679267588,0.0121381391712446
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X46.Hand grip strength (left),50284,-0.0281478348959434,0.00428267758655712,-0.0365418829655954,-0.0197537868262915,4.99646336455328e-11
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X47.Hand grip strength (right),50283,-0.0275857427818072,0.00424954037195847,-0.0359148419108457,-0.0192566436527686,8.5794802297813e-11
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X48.Waist circumference,50422,0.02669717,0.006618338,0.01372523,0.03966912,5.495858e-05
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X4803.Tinnitus,16566,0.0172293501267801,0.0252724421575307,-0.0323046365019801,0.0667633367555402,0.495410022078173
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X4825.Noisy workplace,16776,0.0502154239893621,0.0286324104555709,-0.00590410050355689,0.106334948482281,0.0794836432466187
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X4836.Loud music exposure frequency,16668,-0.0191903453970033,0.0363690816561056,-0.0904737454429703,0.0520930546489636,0.597745505771904
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X49.Hip circumference,50414,-0.00754411367971298,0.00530064639001874,-0.0179333806041497,0.00284515324472375,0.154671596585166
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X50.Standing height,50370,0.0152468654739514,0.00420976115534482,0.00699573360947558,0.0234979973384273,0.000292860271990773
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X5057.Number of older siblings,14807,-0.0163312557466287,0.0227134013075611,-0.0608495223094484,0.028187010816191,0.472143591553553
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X51.Seated height,50150,0.0129027542882381,0.00391382055366076,0.00523166600306304,0.0205738425734132,0.000978903730464253
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5181.Ever had eye surgery,11359,-0.0207974408624678,0.0515818202055158,-0.121897808465279,0.0803029267403431,0.686813676677583
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5186.Duration visual-acuity screen displayed (right),11330,0.0092182828583583,0.00643764620476866,-0.00339950370298827,0.0218360694197049,0.152190402358413
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5188.Duration visual-acuity screen displayed (left),11328,0.00388039293279524,0.0064883743764362,-0.00883682084501971,0.0165976067106102,0.549816419812443
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5190.Duration at which refractometer first shown (right),11201,0.00670246316828907,0.00653267560239372,-0.00610158101240263,0.0195065073489808,0.304918241386396
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5193.Duration at which refractometer first shown (left),11198,0.00688863611793724,0.00656298590245614,-0.0059748162508768,0.0197520884867513,0.293915898670763
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5199.logMAR, initial (right)",11292,0.00497325607506498,0.0267920385213166,-0.0475391394267155,0.0574856515768455,0.852742656142312
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5200.Final number of letters displayed (right),11292,0.409315648810696,0.155063705763833,0.105390785513584,0.713240512107808,0.00831031520486293
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5201.logMAR, final (right)",11184,-0.000419505641694257,0.00653957267694917,-0.0132370680885146,0.0123980568051261,0.948852904879763
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5202.Number of rounds to result (right),11292,-0.00784057676523365,0.0253698355133932,-0.0575654543714844,0.0418843008410171,0.757288334640039
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5206.logMAR, initial (left)",11284,0.0304023451709262,0.0270492634999124,-0.0226142112889021,0.0834189016307545,0.261053075176407
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5207.Final number of letters displayed (left),11284,-0.0952492223007629,0.166512423561777,-0.421613572481845,0.23111512788032,0.567316639401089
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5208.logMAR, final (left)",11176,0.00547294848062695,0.00654130197511377,-0.00734800339059604,0.0182939003518499,0.402792787150497
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5209.Number of rounds to result (left),11278,0.0145852302533862,0.0252859342184001,-0.034975200814678,0.0641456613214504,0.564078001165045
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",10797,-0.0111120194170262,0.00648836528728405,-0.0238292153801029,0.00160517654605057,0.0868136249763969
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",10797,-0.00975351162136476,0.00645839158442396,-0.0224119591268357,0.0029049358841062,0.131019778378891
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5256.Corneal hysteresis (right),10797,0.00137111110362141,0.00654343389599158,-0.0114540193325221,0.0141962415397649,0.834030675551238
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5257.Corneal resistance factor (right),10797,-0.00384018683653152,0.00650917830287132,-0.0165981763101593,0.00891780263709626,0.55522653238541
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",10771,-0.0082416041126108,0.00650427302039227,-0.0209899792325797,0.00450677100735806,0.205144781119362
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",10771,-0.00995411778484733,0.0064501392731618,-0.0225963907602445,0.0026881551905498,0.122801788713956
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5264.Corneal hysteresis (left),10771,0.00190940277050362,0.00657597602823405,-0.0109795102448351,0.0147983157858423,0.771546162837264
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5265.Corneal resistance factor (left),10771,-0.00225724756372377,0.0065106991297757,-0.0150182178580841,0.0105037227306366,0.728824856346947
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,11275,-0.0148301187830807,0.120839649192634,-0.251675831200643,0.222015593634481,0.90232657930906
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",50266,-0.00105651628053549,0.0171621976070968,-0.0346944235904452,0.0325813910293742,0.950912947892833
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",50266,0.0251038164767125,0.0187269704634712,-0.0116010456316911,0.061808678585116,0.180083481686669
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",50266,0.0248406357204969,0.0178191433524171,-0.0100848852502406,0.0597661566912345,0.16331106071865
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",50266,-0.00246433236856007,0.00760943701292198,-0.0173788289138871,0.012450164176767,0.746051336486268
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",50266,-0.00571004669003138,0.00700445203687429,-0.019438772682305,0.00801867930224223,0.414960280541186
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",22676,-0.010589637016679,0.00887709396174574,-0.0279887411817006,0.00680946714834266,0.232914338225665
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",22676,-0.00162749792720628,0.0241805981391946,-0.0490214702800276,0.0457664744256151,0.946338740633179
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",22676,0.00570139668221812,0.0172331589210751,-0.0280755948030891,0.0394783881675254,0.740769351195611
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",22676,0.0144920369393413,0.010498127847479,-0.00608429364171756,0.0350683675204002,0.167464787879633
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,50414,-0.0183004001446015,0.0117448946202227,-0.0413203936002379,0.00471959331103494,0.119202104859191
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,50414,0.0309202798543896,0.0150593848713063,0.00140388550662927,0.0604366742021499,0.0400560755438857
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),50414,-0.00650935801118947,0.0115948709250878,-0.0292353050243615,0.0162165890019826,0.574527528636416
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',50414,-0.0399175378038171,0.0191201419375239,-0.077393016001364,-0.00244205960627027,0.0368279427462549
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),50414,-0.0393078496086893,0.0461185793779814,-0.129700265189533,0.0510845659721543,0.394039812168399
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),50414,0.0172151082316869,0.0320125210842803,-0.0455294330935024,0.0799596495568763,0.590743940889514
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,50414,0.0333098568732455,0.0507334484050074,-0.0661277020005691,0.13274741574706,0.511463019650706
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,50265,0.00972260260313548,0.00976192900562622,-0.00941077824789191,0.0288559834541629,0.319268812126134
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,50265,0.0231307146047336,0.0165776024795536,-0.0093613862551914,0.0556228154646587,0.16293181511536
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,50265,0.0114683006100233,0.00874900401546345,-0.00567974726028506,0.0286163484803317,0.189927232913038
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,50265,0.0300315469671675,0.014621589099073,0.00137323233298434,0.0586898616013506,0.0399887781558164
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,50265,0.0192760309363917,0.0144971840310991,-0.00913844976456248,0.0476905116373459,0.183643057915289
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,50265,0.0489886774834037,0.00816429671937065,0.0329866559134372,0.0649906990533702,1.98230190907368e-09
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,15634,0.0271604499060923,0.019774643731679,-0.0115978518079986,0.0659187516201832,0.169617039228216
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,15634,-0.0295125315755561,0.0169399478884248,-0.0627148294368687,0.00368976628575642,0.0814956725933055
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,15634,0.0467945103512421,0.0234427875016672,0.000846646847974447,0.0927423738545098,0.0459386875888754
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,15634,0.0338873327731109,0.0186847640521178,-0.00273480476903996,0.0705094703152617,0.0697531961226828
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,50206,0.0637930380741613,0.0247215436120194,0.0153388125946032,0.112247263553719,0.00986959507104668
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#2.Fractured bone site(s)_Leg,50206,0.0145519677608758,0.0365581501829028,-0.0571020065976136,0.0862059421193652,0.690595101704309
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#3.Fractured bone site(s)_Hip,50206,0.324916080872414,0.0657424105173001,0.196060956258506,0.453771205486322,7.74704706258583e-07
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#4.Fractured bone site(s)_Spine,50206,0.136897350709651,0.0632724335439306,0.0128833809635473,0.260911320455755,0.0304984125973914
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,50206,0.00433239849552955,0.0215215912862759,-0.0378499204255713,0.0465147174166304,0.840461106473618
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#6.Fractured bone site(s)_Arm,50206,-0.0122615596453379,0.0286926680740279,-0.0684991890704326,0.0439760697797568,0.66913265042054
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,50206,0.00428665166307001,0.0132583005575951,-0.0216996174298164,0.0302729207559564,0.746455516589101
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",16253,0.0492267531832325,0.0212537940331385,0.00756931687828109,0.0908841894881838,0.0205630379419815
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",16253,0.0410615908521673,0.0226871606691989,-0.00340524405946255,0.0855284257637972,0.0703290996720919
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",16253,0.0694255315012079,0.031014935686534,0.00863625755560127,0.130214805446814,0.0252049070743897
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",16253,0.00933383090980087,0.0108822744515099,-0.0119954270151586,0.0306630888347603,0.391065514099703
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",22823,0.0180024645503922,0.0101307634245183,-0.00185383176166373,0.0378587608624482,0.0755799728470318
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",22823,-0.0304787027930247,0.00989171134365708,-0.0498664570265926,-0.0110909485594568,0.00206388251610471
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",22823,-0.00160189791790937,0.00904006637031138,-0.0193204280037197,0.0161166321679009,0.859353029201891
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",22824,0.0315700553256796,0.0214181368757875,-0.0104094929508639,0.0735496036022232,0.140498891428877
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",22824,0.0187598010631205,0.0128268475090131,-0.0063808200545453,0.0439004221807862,0.143606567113616
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",22824,0.00397850654783241,0.0173197793759787,-0.0299682610290858,0.0379252741247506,0.818320079645253
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,50265,-0.0322555457520676,0.020335286304588,-0.0721127069090601,0.00760161540492493,0.112703422458295
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,50265,0.00109030336726943,0.014333904556404,-0.0270041495632824,0.0291847562978213,0.939367970314017
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,50265,0.0689532221653702,0.0397755319369025,-0.00900682043095878,0.146913264761699,0.0830025352990121
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,50265,-0.0272620416064798,0.0147277687549309,-0.0561284683661442,0.00160438515318474,0.064166219234331
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,50265,-0.0313526758039282,0.0167269961913185,-0.0641375883389125,0.00143223673105613,0.0608844521186731
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),50265,0.0610163206882494,0.0192458362889968,0.0232944815618158,0.098738159814683,0.00152339054179302
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,50265,0.0196808278724748,0.00633791214480836,0.00725852006865039,0.0321031356762991,0.00190221306536727
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,9812,0.0400173000997389,0.0185515717894682,0.00365621939238121,0.0763783808070966,0.0310233545855843
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,9812,0.0828108900991392,0.023203597855076,0.0373318383031903,0.128289941895088,0.000360222737657421
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,9812,-0.0278113877489801,0.0164341270233655,-0.0600222767147765,0.00439950121681632,0.0906215732728974
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,9812,-0.00389061471984151,0.0146724525559077,-0.0326486217294205,0.0248673922897375,0.790888257749896
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,50489,-0.00385389054983393,0.00742480774030338,-0.0184065137208286,0.0106987326211607,0.603724008975151
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,50489,0.0157939607475464,0.0212580007084883,-0.0258717206410906,0.0574596421361835,0.457506036581896
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,50489,-0.00416943345093411,0.00693184060140938,-0.0177558410296965,0.00941697412782827,0.547516309427601
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,50489,0.00358372338128609,0.0067109431268417,-0.00956972514732365,0.0167371719098958,0.593335663888159
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,50489,0.0208242061261976,0.0103815965120704,0.000476276962539626,0.0411721352898555,0.044874694252469
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,50489,0.0161317723400174,0.0092637124596247,-0.00202510408084705,0.0342886487608818,0.0816206495685892
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,50489,-0.000420700368709434,0.00720897625861459,-0.014550293835594,0.0137088930981752,0.953463817864969
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,50489,0.0934502328357067,0.021215113460445,0.0518686104532345,0.135031855218179,1.06055256659059e-05
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,34952,-0.03953237623686,0.00728436472108854,-0.0538097310901936,-0.0252550213835265,5.76840159212361e-08
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,34952,0.00710520817992915,0.00760540547115226,-0.00780138654352929,0.0220118029033876,0.350191026862879
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,34952,0.0115234990500584,0.00858267054137822,-0.00529853521104291,0.0283455333111597,0.179394943996222
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,34953,-0.00022425964048737,0.0117444619274844,-0.0232434050183567,0.022794885737382,0.984765487577395
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,34953,-0.0199349917374884,0.00769506705139249,-0.0350173231582177,-0.00485266031675912,0.00958431096729056
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,50033,-0.018991206240379,0.00747241307081872,-0.0336371358591836,-0.00434527662157428,0.0110404973909453
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,50033,-0.0182850708064045,0.0059493218206708,-0.0299457415749193,-0.00662440003788974,0.0021169773572097
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,50033,6.99348653667707e-06,0.00659838568997016,-0.0129258424658048,0.0129398294388782,0.999154343764983
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,50033,-0.0172485633893356,0.0118988726521331,-0.0405703537875165,0.00607322700884535,0.147177360060411
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),50067,-0.0299730425706846,0.00656520194820889,-0.042840838389174,-0.0171052467521952,4.99629878839179e-06
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,50067,-0.0484520159260831,0.0102419577783616,-0.0685262531716718,-0.0283777786804943,2.24314876241007e-06
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),50265,-0.0318830742893149,0.00647313093447604,-0.044570410920888,-0.0191957376577419,8.44337809648575e-07
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,50265,-0.0416469090872097,0.00766427660276823,-0.0566688912286354,-0.0266249269457839,5.53912584254444e-08
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,50265,-0.00666339478864767,0.0115647954798459,-0.0293303939291457,0.0160036043518503,0.564496632745744
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,50265,-0.0441276265330903,0.0146914952028672,-0.0729229571307101,-0.0153322959354705,0.00266922161148552
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,50265,-0.00315181844006447,0.0159984166895547,-0.0345087151515917,0.0282050782714627,0.843821958460512
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,50265,-0.0708356572230817,0.0190111681916785,-0.108097546878772,-0.0335737675673919,0.000194753486333589
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",28597,-0.0128944542823816,0.0040503431806547,-0.0208331269164648,-0.00495578164829841,0.00145638796283363
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X864.Number of days or week walked 10+ minutes,49395,-0.01479909267895,0.0126317755575992,-0.0395573727718444,0.00995918741394436,0.241372740167399
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X874.Duration of walks,42767,-0.00348454738285827,0.00318359840177255,-0.00972440025033247,0.00275530548461593,0.273728292184689
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47748,-0.0320080359279032,0.0122147164245384,-0.0559488801199985,-0.00806719173580801,0.00878419906028269
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X894.Duration of moderate activity,36965,-0.0024039301789707,0.0147898775151802,-0.0313920901087239,0.0265842297507825,0.870882399538286
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X90087.No-wear time bias adjusted average acceleration,10553,-0.0054935529812783,0.00680504780469545,-0.0188314466784814,0.00784434071592479,0.41952560401426
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47670,-0.0616775126440449,0.0125602667248569,-0.0862956354247644,-0.0370593898633254,9.11326648583433e-07
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X914.Duration of vigorous activity,26693,-8.60482504533749e-05,0.00398012527644221,-0.00788709379228011,0.00771499729137336,0.982751653716318
